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 Leptin, a peptide synthesized by adipocytes in the periphery, has been shown to 
play significant roles in feeding and energy expenditure mediated by the hypothalamus. 
Growing evidence supports the role of leptin in influencing synaptic plasticity in the 
hippocampus in that leptin dose-dependently enhances LTP, alters morphology and 
neurogenesis, facilitates spatial learning and memory, as well as memory retention. 
Models of leptin deficiency and resistance have further supported the importance of 
leptin in synaptic plasticity by exhibiting deficits in electrophysiological, morphological 
and behavioral tests that are improved after leptin restoration. The effects of leptin when 
applied directly into the hippocampus have clear effects on synaptic plasticity; however, 
indirect pathways may also be activated by leptin that result in synaptic plasticity changes 
in the hippocampus. Due to the nature of the release of leptin from the peripheral 
adipocytes, the interconnectivity of the brain, and the localization of leptin receptors 
throughout many brain regions, support the hypothesis that leptin could mediate synaptic 
plasticity changes in the hippocampus through multi-synaptic circuitry in addition to its 
direct effects. A variety of brain regions that express leptin receptors project both directly 
and indirectly to the hippocampus, including many nuclei of the hypothalamus, raphe 
nucleus, locus coeruleus and ventral tegmental area and therefore pose as potential 
starting points for brain-wide networks that leptin could influence for the regulation of 
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DIRECT EFFECTS OF LEPTIN IN THE HIPPOCAMPUS 
1.1 SYNAPTIC PLASTICITY: AN INTRODUCTION 
 Synaptic plasticity may be defined as a modification in synaptic strength after a 
repeated stimulus. Changes in synaptic plasticity form the basis for how the brain is able 
to adapt itself in response to stimuli and is part of the proposed mechanism for learning 
and memory. The phenomenon of synaptic plasticity is important because it results in a 
change in efficacy in how neurons respond to a stimulus and therefore the response to the 
stimulus changes. Synaptic plasticity is thought to underlie certain types of learning and 
memory and this is demonstrated in the hippocampus, a well-studied structure shown to 
be integral in particular spatial learning and memory. 
 Synaptic plasticity has many aspects that can be observed and regulated, both 
positively and negatively. Factors such as stress (Gould et al, 1997; Schoenfeld and 
Gould, 2012; Yap et al, 2006) and aging (Kuhn et al, 1996; Seki and Arai, 1995) can 
detrimentally affect learning and memory. Conversely, estrogen (Gould, 1999), the 
neurotransmitter serotonin (Brezun and Daszuta, 1999), an enriched environment 
(Nilsson et al, 1999) and exercise (Praag et al, 1999) can positively modulate synaptic 
plasticity. The 167 amino acid peptide leptin has also been shown to influence synaptic 
plasticity (Maffei et al, 1995). 
 Synaptic plasticity in the hippocampus can be directly altered, for example by 
applying a stimulus directly to neurons to see an enhancement of synaptic plasticity. 
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However, synaptic plasticity also be indirectly affected, through receptors in different 
brain areas projecting to others in such a way that initiation at one area eventually leads 
to the hippocampus to alter synaptic activity. This multi-synaptic circuitry must operate 
through a series of neurons connected by synapses that are inhibited or excited by 
neurotransmitters. Leptin receptors are expressed in regions that have projections to the 
hippocampus and in this manner leptin may be uniquely positioned to directly and 
indirectly affect synaptic plasticity in the hippocampus. 
  
1.2 LEPTIN, LEPTIN RECEPTORS & SIGNALING 
 Leptin, the protein product of the obesity (ob) gene, is predominantly synthesized 
by adipocytes, proportional to the amount of adipocytes in the body (Frederich et al, 
1995). Although leptin is primarily synthesized in the periphery, there is some evidence 
that it can be synthesized in the brain as there is evidence of the presence of leptin mRNA 
and protein in some brain regions, including the cerebral cortex and hypothalamus 
(Elmquist et al, 1998). Leptin mRNA transcription in the hypothalamus has been shown 
to be blunted when fasting occurs and leptin levels have also been shown to fall during 
starvation (Morash et al, 1999; Frederich et al, 1995). 
 Once leptin is released into circulation, for example after eating, leptin can act in 
the periphery to play roles in immunity, (Lord et al, 1998; Oomura et al, 2006), inhibit 
insulin secretion, (Bjorbaek and Kahn, 2004), control sex hormone release (Yu et al, 
1997; Ahima et al, 1996) and lipolysis in adipocytes (Siegrist-Kaiser et al, 1997; Wang et 
al, 1999). Leptin receptors in the body have been found in skeletal muscle, heart, lungs, 
liver, white adipose tissue, adrenal glands and the kidneys (Tartaglia et al, 1995; Lee et 
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al, 1996; Fei et al, 1997; Ghilardi and Skoda, 1997; Hoggard et al 1997; Bjorbaek and 
Kahn, 2004). Peripheral leptin receptors are expressed as the short form of the receptor, 
ObRa, and while the exact functions of peripheral ObRa are still not known, there is 
evidence of signaling in pancreatic β cells, pituitary cells, hepatocytes, muscle cells and 
adipocytes (Hileman et al, 2002; Bjorbaek and Kahn, 2004). Leptin has been shown to 
activate PI3K pathways for signaling in insulinoma cells (Harvey et al, 2000), 
hepatocytes (Zhao et al, 2000), and muscle cells (Berti et al, 1997). 
 Leptin can also cross the blood-brain barrier (BBB) through a saturable transport 
system to then act in the central nervous system (CNS) (Banks et al, 1996; Hileman et al, 
2002; Banks et al, 2006). The role of leptin in the CNS has been described as being 
regulatory, where leptin acts as a retrograde modulator (Harvey et al, 2007; Ludwig and 
Pittman, 2003). In the CNS, leptin activates the long isoform of the leptin receptor, the 
ObRb, a class 1 cytokine receptor encoded by the diabetes (db) gene (Tartaglia et al, 
1995). There are six leptin receptor isoforms; ObRa, ObRb, ObRc, ObRd, ObRe and 
ObRf but only the long isoform, ObRb, is capable of complete JAK/STAT signal 
transduction (Baumann et al, 1996; Ghilardi et al, 1996; Bahrenberg et al, 2002; Tartaglia 
et al, 1995). 
  The ObRb is often paired with the JAK/STAT specific subtypes, JAK2/STAT3, 
JAK2/STAT5, and JAK2/STAT6 (Ghilardi et al, 1996) although other pathways can be 
used including the MAPK, and PI3K pathways (Bjorbaek et al, 2004; Niswender et al, 
2001; Zhao et al, 2002; Rahmouni et al, 2003; Cota et al, 2006, 2008). 
 In JAK/STAT signaling, leptin binds to its receptor and initiates a conformational 
change to phosphorylate tyrosine residues on JAK2. The now phosphorylated JAK2 
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stimulates phosphorylation of tyrosine residues on the ObRb receptor, which then recruits 
Src-homology2 and Src-homology 3 that contain within them signal transducer and 
activator of transcription 5 (STAT5) and STAT3. STAT5 and STAT3 are then in turn 
phosphorylated by JAK2 and STAT5 and STAT3 can now separate off of the ObRb and 
dimerize, moving into the nuclear envelope for gene transcription regulation (Marwarha 
and Ghribi, 2012).  Phosphorylated tyrosine residues can recruit STAT family 
transcription factors, phosphoinositide 3-kinase and proteins in the MAPK/Ras Raf 
signaling pathways (Tartaglia et al, 1995; Harvey, 2003).  
 The MAPK pathway also involves phosphorylation of tyrosine residues and 
downstream processes similar to JAK/STAT signaling and can similarly regulate gene 
expression in the CNS (Marwarha and Ghribi, 2012). The PI3K pathway is also activated 
by leptin signaling with the ObRb and utilizes the phosphorylation of Akt at serine 
residues in a similar process to that of JAK/STAT signaling (Vecchoine et al, 2002). 
Studies have also indicated that leptin can activate the AMPK-SIRT1 pathway 
(Yamagishi et al, 2001; Minokoshi et al, 2002; Suzuki et al, 2007).  
 JAK/STAT pathway has been shown to be critical in the actions of leptin in body 
weight regulation (Bates et al, 2003). PI3K signaling is proposed to be involved in leptin-
stimulated reductions in food intake as well as activation of sympathetic nervous system 
activity (Zhao et al, 2002b; Rahmouni et al, 2003).   
 Leptin receptor mRNA has been found in many different brain regions including 
the pituitary, arcuate nucleus, dorsomedial hypothalamus (DMH), ventromedial nucleus 
(VMH), ventral premammillary nucleus, lateral hypothalamus, thalamic nuclei, 
cerebellum and choroid plexus and the hippocampus (Elmquist et al, 1998; Morash et al, 
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1999). Using in situ hybridization, it was found that specific areas of the hypothalamus 
show high levels of leptin receptor expression, including the arcuate nucleus, DMH and 
VMH (Schwartz et al, 1996). Additionally, specific areas of the hippocampus also have 
high levels of immunoreactivity of the leptin receptor, including areas CA1, CA2, CA3 
and the dentate gyrus in particular on neurons and glial cells (Ur et al, 2002; Mercer et al, 
1996; Hakansson et al, 1998; Huang et al, 1996; Shanley et al, 2002). Hippocampal cell 
culture studies have allowed for the localization of leptin receptor expression and have 
revealed that leptin receptors are expressed on the dendrites and axons of neurons, in 
close proximity to NMDA receptors (Shanley et al, 2002b; O’Malley et al, 2007). 
 In contrast to the ObRb’s role in signaling, the ObRa short-form leptin receptor 
may be involved in receptor-mediated transport of leptin across the BBB (Hileman et al, 
2002). The ObRa mRNA is found in high levels in the choroid plexus and brain 
microvessels of the BBB (Tartaglia et al, 1995; Bjorbaek et al, 1998). In support of this 
hypothesis, knock out mice for short form leptin receptors resulted in decreased leptin 
transport across the BBB (Bjorbaek et al, 1998; Hileman et al, 2002). These results 
suggest that the ObRb is the main signaling receptor isoform in the brain while the ObRa 
is used for transport across the BBB. 
 
1.2.1 LEPTIN IN THE HYPOTHALAMUS: FUNCTIONS IN FEEDING & ENERGY 
EXPENDITURE 
 There are many well-studied functions that leptin regulates through activation of 
leptin receptors expressed in the hypothalamus, including regulation of metabolism, 
energy homeostasis, body composition and feeding behaviors (Zhang et al, 1994; Ahima 
et al, 1996; Elmquist, 1999; Elias et al, 1999). Triglycerides are deposited into adipocytes 
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in amounts associated with how much food is being consumed and the amount of stored 
triglycerides determine how much leptin mRNA and plasma leptin protein is produced 
(Kulcsar et al, 2005). As such, leptin serves as an adiposity indicator, secreted in 
proportion to the amount of fat stored and higher levels of leptin decrease food intake and 
increase energy expenditure (Schwartz et al, 2000). Direct injection of leptin in animals 
lacking leptin or proper leptin receptor functioning into the hypothalamus resulted in a 
significant decrease in feeding as well as fat and weight loss (Zhang et al, 1994; Morton 
et al, 2006).  
 Leptin suppresses food-seeking behaviors by inhibiting neuropeptide Y 
(NPY)/AgRP and orexin neurons and activating POMC/CART neurons in the arcuate 
nucleus (Huang et al, 1996; Cowley et al, 2001). These populations of neurons project to 
the lateral hypothalamus for well-studied control of food intake (Elias et al, 1999; Mercer 
et al, 1996a; Cheung et al, 1997). These roles of leptin in the regulation of feeding and 
energy metabolism mediated through the lateral and arcuate nuclei of hypothalamus lend 
understanding to the functional activity of leptin outside of the hypothalamus in brain 
regions such as the hippocampus. 
 
1.3 THE HIPPOCAMPUS 
 As noted above, the ObRb mRNA and protein are expressed in many brain 
regions including the hippocampus (Hakansson et al, 1998; Elmquist et al, 1998; Haung 
et al, 1996). The hippocampus, part of the limbic system involved in learning and 
memory, is comprised of layers of pyramidal cells which are then divided into different 
areas, Cornu Ammonis regions 1-4 (CA1-4). The structure of the hippocampus is such 
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that information flows in one direction and follows a series of pathways. Information 
enters the hippocampus from the entorhinal cortex through the perforant path to the 
dentate gyrus. Axons project from the dentate gyrus, projections called the Mossy Fiber 
Pathway, to area CA3 of the hippocampus, also pyramidal neurons. Projections from area 
CA3, the Schaffer Collaterals/Commissural Pathway, project to area CA1 which then 
projects to the subiculum and entorhinal cortex and exit the hippocampus. Leptin 
receptors are found in areas CA1, CA3 and the dentate gyrus, areas where synaptic 




LEPTIN & SYNAPTIC PLASTICITY IN THE HIPPOCAMPUS 
2.1 LEPTIN & LTP 
 Long-term potentiation (LTP) and long-term depression (LTD) are activity-
dependent forms of hippocampal synaptic plasticity and are considered as being cellular 
correlates for learning and memory, or the most fundamental units of measuring learning 
and memory. LTP is a greater response and LTD is a lesser response of a neuron that 
occurs after high-frequency stimulation, as assessed using electrophysiological 
techniques (Bliss and Lomo, 1973; Bliss and Gardner-Medwin, 1973). Electrophysiology 
is a technique used to measure electrical activity in neurons or cells. A glass micropipette 
filled is inserted into a neuron or cell and another electrode is inserted into the 
surrounding fluid around the cell for reference. Voltage can be clamped to hold the 
membrane potential so that current can be measured. Current can be clamped in a similar 
fashion so that current is applied and membrane potential can be measured. Using 
different electrophysiology clamping and recording techniques, it is possible to determine 
when channels are opened by a stimulus or when neurons are activated.  
 LTP is important in learning and memory, as evidenced by when LTP induction is 
blocked, impairments in memory are seen (Grant and Silva, 1994). Mutations in a gene 
encoding a particular tyrosine kinase involved in LTP resulted in impairments in LTP in 
area CA1 as well as spatial learning deficits, demonstrating the importance of LTP in 
spatial learning (Grant et al, 1992; Bliss and Collingridge, 1993).  
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 LTP occurs at all excitatory synapses in the hippocampus and other areas of the 
brain (Doyere et al, 1992). LTP has been shown to last for hours in hippocampal slices 
and days in animals that have had LTP induced (Bliss and Collingridge, 1993). The 
enhanced response seen by a neuron after high-frequency stimulation occurs is proposed 
as being a combination of several events, which may include increased neurotransmitter 
release by the presynaptic neuron, increased number of receptors localized to the 
activation of the synapse and less uptake of neurotransmitter by nearby glial cells (Bliss 
and Collingridge, 1993). 
 LTP can be N-methyl-D-aspartate (NMDA) receptor-dependent in the Perforant 
pathway and Schaffer collaterals in the hippocampus and also NMDA receptor-
independent in the Mossy Fiber pathways (Bliss and Collingridge, 1993). The NMDA 
receptor is a type of glutamate receptor and is involved in synaptic plasticity in the 
hippocampus (Lisman et al, 2012). NMDA antagonists block LTP induction, 
demonstrating the necessity of NMDA receptors in initializing LTP (Bliss and 
Collingridge, 1993).  
 NMDA receptor activation is critical for LTP to occur, the more the NMDA 
receptors involved in propagating signal, the more likely that LTP will initiate in the 
perforant pathway and Schaffer collaterals, those pathways whose LTP is NMDA 
receptor-dependent (Malenka, 1994; Collingridge et al, 1983). NMDA-dependent LTP is 
made possible due to several unique properties of the receptor itself. NMDA receptors 
contain a magnesium plug that blocks the channel until the membrane potential is 
sufficiently depolarized and thus the NMDA receptor is referred to as being voltage-
dependent (Ascher and Nowak, 1988). In addition, simultaneous glutamate binding to 
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NMDA receptor must occur and so the NMDA receptor is a ‘coincidence detector’ due to 
the several conditions that must be met at once for the channel to open (Ascher and 
Nowak, 1988). Once the channel is open, calcium flows through and increases 
intracellular calcium, beginning a cascade of signaling events that lead to LTP. As 
intracellular calcium levels increase, calcium binds to calmodulin and this complex 
activates calcium/calmodulin-dependent protein kinase II (CaMKII), which has been 
identified as an important component of NMDA-mediated LTP (Lisman et al, 2012).  
CaMKII is important in the induction of LTP and knockdown of an isoform of CaMKII 
has been shown to impair hippocampal slice LTP (Silva et al, 1992a; Malinow et al, 
1989). Leptin can influence many aspects of LTP and LTD mediated through ObRb 
receptors in the CA1, CA3 and the dentate gyrus regions of the hippocampus (Mercer et 
al, 1996; Oomura et al, 2006; Shanley et al, 2001; Shanley et al, 2002; Xu et al, 2008).  
 Leptin application shifts short-term potentiation (STP) to LTP (Shanley et al, 
2001). STP is similar to LTP in that it is an increased response to tetanus stimulation, 
however it persists for only seconds to minutes. Hippocampal slices were used to show 
STP conversion after stimulation of the Schaffer collateral commissural pathway 
(Shanley et al, 2001; Harvey et al, 2007). STP was evoked in hippocampal slices that 
lasted about 30 minutes (Shanley et al, 2001). If the slice was incubated with leptin 
immediately preceding the primed burst stimulation to evoke STP, then STP was 
converted into LTP that lasted for an hour (Shanley et al, 2001).  
 Leptin enhances and suppresses NMDA receptor-dependent LTP in a dose-
dependent manner (Oomura et al, 2006; Wayner et al, 2004). Electrophysiology studies at 
the Schaeffer collaterals in the hippocampus showed that leptin application resulted in 
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enhancement of LTP by 163% compared to controls (Oomura et al, 2006). Leptin 
application dose-dependently enhanced LTP with the lowest and highest doses resulting 
in reducing LTP, resulting in an inverted U dose response (Oomura et al, 2006). Leptin 
also enhances LTP in other areas of the hippocampus, including the dentate gyrus 
(Wayner et al, 2004). Hippocampal slice studies show similar results, LTP was induced 
by bath administration of leptin (Li et al, 2002; Shanley et al, 2001; Wayner et al, 2004). 
Interestingly, age can affect the ability of leptin to increase excitatory transmission. In 
this regard, it was shown that in hippocampus slices from juvenile rodents that leptin 
decreases excitatory transmission, which is contrary to what occurs in adults (Moult et al, 
2010; Moult and Harvey, 2011). This has been proposed to being related to the process of 
brain development (Irving and Harvey, 2014). 
 In addition to changes in LTP, changes in excitatory postsynaptic potentials 
(EPSCs) were found with leptin application. Leptin receptor signaling resulted in 
increases in NMDA receptor excitatory postsynaptic currents (EPSCs) in area CA1 but 
decreases AMPA receptor EPSCs (Shanley et al, 2001). In further support, 
electrophysiological studies for field potentials in CA1 pyramidal neurons revealed 
significant increases in mEPSC amplitude through NMDA receptors dependent on the 
dose of leptin (Oomura et al, 2006). It has been shown that leptin receptors are required 
for this effect by using Xenopus oocytes with variable NMDA receptor composition and 
the ObRb. 
 Leptin enhanced NMDA EPSCs with the NR1/NR2A subunits of the NMDA 
receptor with the ObRb present (Shanley et al, 2001). When the ObRb was eliminated, 
leptin did not enhance currents with the NMDA subunits NR1/NR2A when NMDA was 
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applied (Shanley et al, 2001). It has been proposed that leptin may traffic NMDA 
receptors to the membrane to affect the increased current through NMDA receptors, just 
as insulin has been shown to do (Shanley et al, 2001; Harvey et al, 2007; Skeberdis et al, 
2001). These studies collectively show that leptin and the leptin receptor directly effect 
LTP and EPSCs through several mechanisms in the hippocampus.  
 Leptin enhances calcium influx through NMDA receptors and also increases the 
activity of CaMKII (Shanley et al, 2001; Oomura et al, 2006). Calcium influx into 
postsynaptic neurons is vital in the induction step of LTP and leptin is able to increase 
calcium flux into hippocampal CA1 neurons via NMDA receptors (Bliss and 
Collingridge, 1983; Oomura et al, 2006). Calcium concentration was measured in single 
neurons from area CA1 of the hippocampus in response to leptin. Leptin application 
dose-dependently resulted in increases in calcium in the same inverted U dose response 
as seen with LTP (Oomura et al, 2006).  
 It was also determined that leptin increases calcium flow through NMDA 
receptors as part of the induction phase of LTP (Shanley et al, 2001). Hippocampal cell 
cultures showed that leptin quickly enhanced inward flow of calcium through NMDA 
receptors in postsynaptic neurons after NMDA was applied (Shanley et al, 2001). To 
further support the ability of leptin to increase calcium mediated by NMDA receptors, it 
was shown that without the NMDA receptor agonist NMDA, leptin did not enhance 
calcium levels (Shanley et al, 2001). Additionally, leptin had no effect on calcium 
increase facilitated by AMPA receptors (Shanley et al, 2001).  To determine which 
signaling pathways were involved, PI3K signaling was blocked with LY 294002 and 
wortmannin which resulted in a significant reduction in the ability of leptin to enhance 
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calcium influx into neurons. Similar experiments blocking MAPK signaling with PD 
98059 and U0126 resulted in a reduction of the ability of leptin to enhance NMDA 
currents as well as calcium influx (Shanley et al, 2001). This supports the idea that leptin 
increases calcium through MAPK and PI3K-dependent mechanisms.   
 CaMKII is an enzyme involved in signal transduction in LTP and has been shown 
to be involved in LTP maintenance as well as play critical roles in learning and memory 
(Fukunaga et al, 1993; Silva et al, 1992; Oomura et al, 2006). CaMKII activity was 
assessed using an assay and results showed that leptin at the same dose that increased 
calcium concentration increases CaMKII activity, whereas this effect on CaMKII was not 
seen at other doses of leptin (Oomura et al, 2006). These data collectively show that 
leptin increases calcium influx through NMDA receptors in the postsynaptic neuron and 
increases CaMKII activity dose-dependently (Oomura et al, 2006).  
 Leptin can also reverse LTP, a process called depotentiation, at area CA1. 
Depotentiation is important in preventing potentiated synapses from becoming saturated 
and to aid neurons in storing information (Harvey, 2013; Moult et al, 2009). The ability 
of leptin to depotentiate synapses is dependent on the dose administered and time course 
(Moult et al, 2009). Rapid depotentiation was seen with the highest doses of leptin 
compared to lowest doses of leptin. The time after LTP induction is also important, 30 
minutes after LTP was induced, leptin was given and LTP was completely reversed. 
However, leptin administrated after 50 minutes did not change LTP (Moult et al, 2009). 
This reversal is NMDA-receptor dependent and involves rectification of currents through 
AMPA receptors which has been proposed as being a result of an alteration of subunits of 
AMPA receptors (Moult et al, 2009).  
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 Leptin can also induce NMDA receptor-dependent LTD when excitability is 
enhanced (Durakoglugil et al, 2005). LTD is the weakening of synapses after repeated 
stimulus and has been identified as an important aspect of some forms of learning and 
memory processing (Bear and Abraham, 1996). Part of the mechanism of the lesser 
response with LTD has been proposed to involve withdrawing AMPA receptors from the 
membrane and the reduction of dendritic spines (Nagerl et al, 2004). GABA A receptors 
normally inhibit the activation of NMDA receptors due to its ability to increase the 
intensity of the magnesium blocking of the NMDA receptor. In hippocampal slices with 
magnesium removed or with picrotoxin, a GABA A receptor antagonist, leptin 
application resulted in LTD. In the same study, it was shown that NMDA receptors are 
required for the LTD to occur (Durakoglugil et al, 2005). Additionally, wortmannin and 
LY294002, blockers of PI3K signaling, further increased the depressive response induced 
by leptin. It can then be inferred that PI3K signaling is involved in inhibiting leptin-
induced LTD (Durakoglugil et al, 2005).  
 Leptin binding to its receptors can activate three different signaling pathways 
linked to the ObRb: JAK/STAT, PI3K and MAPK (Ghilardi et al, 1996; Banks et al, 
2000; Bjorbaek et al, 2000; Niswender et al, 2001; Zhao et al, 2002; Rahmouni et al, 
2003; Cota et al, 2006, 2008). However, in regard to synaptic plasticity changes, the 
JAK/STAT pathway is the unlikely candidate for the signaling pathway because 
JAK/STAT initiates gene transcription and synaptic changes occur rapidly. Instead, there 
is evidence that leptin utilizes the PI3K and MAPK pathways for signaling that alters 
NMDA receptor function due to the ability of these pathways to have fast-acting 
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responses (Shanley et al, 2001). In the hippocampus, neurons express PI3K (Folli et al, 
1994) and MAPK signaling (Fiore et al, 1993). 
 PI 3-kinase inhibitors LY 294002 and wortmannin with leptin decreased the 
ability of leptin to facilitate NMDA-receptor dependent calcium increases (Shanley et al, 
2001). This demonstrates that the ability of leptin to enhance the increase of calcium 
through NMDA receptors is dependent on PI3K signaling. MAPK signaling pathways 
have been shown to play a role in hippocampal synaptic plasticity (Impey et al, 1999; 
Rosenblum et al, 2000). One study inhibited MEK activity using PD 98059 and U0126 to 
study if MAPK pathways were being utilized by leptin for some of the rapid NMDA 
EPSC changes. Blocking MEK with either PD 98059 or U0126 decreased the 
enhancement of NMDA receptor currents by leptin (Shanley et al, 2001). From these 
studies that inhibited either PI3K or MEK in the MAPK pathways, it can be concluded 
that leptin uses these pathways for at least some of the rapid synaptic plasticity changes 
seen in the hippocampus. 
 To further support this idea, experiments were completed in the arcuate nucleus to 
demonstrate the rapid effects of PI3K signaling by leptin to depolarize POMC neurons. 
PI3K is activated by phosphorylated IRS proteins so that the PI3K enzyme can in turn 
phosphorylate phosphatidylinositol to have downstream effects (Shyng and Nichols, 
1998). Loose-patch recordings of POMC neurons showed that leptin application 
increases firing rate, as seen in other experiments (Hill et al, 2008; Williams and Smith, 
2006; Williams et al, 2007; van den Top et al, 2004; Munzberg et al, 2007). Transgenic 
mice with impaired PI3K signaling in POMC neurons provided additional evidence that 
PI3K is required by leptin for rapid signaling by showing that leptin application failed to 
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increase firing rates of POMC neurons (Hill et al, 2008). Additionally, wortmannin 
blocked the effects of leptin on firing rate of POMC neurons whereas a MAPK inhibitor 
did not (Hill et al, 2008). Therefore, leptin signals with the PI3K pathway in the 
hypothalamus to rapidly depolarize POMC neurons. Although this study was conducted 
in the hypothalamus, the data show that leptin can signal quickly with PI3K which is 
similar to what has been found in the hippocampus (Shanley et al, 2001). 
 Enhancing NMDA responses, as leptin has been shown to do, involves PI3K, 
MAPK signaling and Src tyrosine kinases (Shanley et al, 2001). This is evidenced by 
experiments showing that the inhibition of tyrosine kinases blocks the induction of LTP 
(Salter, 1998; O’Dell et al, 1991). Phosphorylation and Src tyrosine kinases are involved 
in the improvement of NMDA function (Yu et al, 1997; Zheng et al, 1998; Salter et al, 
1998; MacDonald et al, 1989; O’Dell et al, 1991).  Using lavendustin A to block tyrosine 
kinases in the hippocampus reduced the ability of leptin to enhance calcium influx 
mediated by NMDA receptors (Shanley et al, 2001). If Src tyrosine kinase inhibitors 
were applied in hippocampal slices, leptin application no longer resulted in increased 
EPSCs. These data imply that Src tyrosine kinases are involved in the ability of leptin to 
enhance EPSCs and calcium influx (Shanley et al, 2001). It is clear, then, that tyrosine 
kinases play an important role in NMDA receptor function and leptin-mediated 
enhancement of NMDA receptor functions. 
 In addition to leptin influencing glutamatergic receptors, such as NMDA and 
AMPA receptors, leptin has been shown to increase GABAergic synaptic transmission 
onto CA3 neurons in rats (Shanley et al, 2001; Guimond et al, 2014). Whole-cell patch 
clamping studies on CA3 pyramidal neurons showed that miniature GABA A receptor-
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mediated postsynaptic currents were increased after leptin was added to the perfusion 
solution (Guimond et al, 2014). Further studies concluded that leptin achieves this 
through calcium influx in the postsynaptic neuron involving the PI3K and MAPK 
signaling pathways (Guimond et al, 2014). In addition, leptin can also affect GABAergic 
transmission onto CA1 pyramidal neurons. Hippocampal slices were used to determine 
the effect of bath application of leptin on inhibitory postsynaptic current (IPSC) 
amplitude. This effect was also dose-dependent with the higher doses of leptin resulting 
in a higher evoked IPSC amplitude whereas lower doses had no effect. The heightened 
IPSC amplitude disappeared after leptin was washed out and so was not a long-term 
effect (Solovyova et al, 2009). Inhibition of PI3K signaling blocked this leptin- induced 
increase in IPSC amplitude. These studies add to the existing body of literature that leptin 
is neuromodulatory and can modulate many different types of neurotransmission, 
including glutamatergic and GABAergic transmission. 
 Leptin can also alter glutamate receptor trafficking to the membrane which is 
important in LTP. For example, leptin treatment of hippocampal slices increased the 
expression of the GluR1 and GluR2 AMPA receptor subunit in the cell surface via 
exocytosis (Moult et al, 2010). Additionally, leptin increases the amount of AMPA 
receptors that are permeable to calcium which lead to an increase in phosphatidylinositol 
trisphosphate (PIP3). This is proposed as being a part of the process of GluR1 trafficking 
to the membrane (Moult et al, 2010). To determine at which area of the neuron GluR1 
expression is increased, immunocytochemistry with synapsin-1 was completed and it was 
found that GluR1 and synapsin-1 colocalize, showing that GluR1 expression is increased 
at synapses (Moult et al, 2010). It was also shown that leptin receptors and NMDA 
 
18 
receptors were required for these effects. Collectively, these studies show that leptin 
increases glutamate receptor trafficking at the synapses of hippocampal neurons, which 
may be an important component of leptin-mediated induction of LTP.  
 The proteins growth-associated protein 43 (GAP-43) and synaptosomal-
associated protein 25 (SNAP-25) are implicated in being involved in the maintenance 
phase of LTP and have been shown to be influenced by leptin. For example, 
phosphorylated GAP-43 is important in transitioning from LTP induction to LTP 
maintenance (Reymann et al, 1988; Leahy et al, 1993). SNAP-25 is also involved in LTP, 
as blocking SNAP-25 function resulted in blocking LTP (Roberts et al, 1998). These 
proteins are both located presynaptically and can be regulated by leptin (Ahima et al, 
1999). When leptin is deficient or absent, SNAP-25 is decreased and GAP-43 is 
increased 3-fold. Both proteins return to normal levels once leptin is applied (Ahima et al, 
1999). In a leptin deficient model, there are dysregulated/abnormal levels of SNAP-25 
and GAP-43 signaling molecules. This shows the importance of leptin in synaptic 
proteins that have been directly linked to the maintenance phase of LTP and spatial 
memory (Ahima et al, 1999; Reymann et al, 1988; Leahy et al, 1993).  
 
2.2 LEPTIN & MORPHOLOGY 
 Dendritic spines are projections on the dendritic shaft that can number in the 
thousands per dendrite and are a major site of excitatory input from a presynaptic neuron 
(Gray, 1959; Harris and Kater, 1994; Shepherd, 1996; Muller and Connor, 1991; Yuste 
and Denk, 1995; Yuste and Bonhoeffer, 2001). Spines are able to control how long 
transient calcium is present, an important aspect of synaptic plasticity (Lynch et al, 1983; 
Malenka et al, 1989). There are several types of shapes of dendritic spines: thin with a 
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small spine head and long spine neck, mushroom-shaped with a larger head and short 
neck, or stubby with only a small protrusion. The shape of the dendritic spines can impact 
synaptic transmission and the shape and number of spines have been linked to learning, 
memory, depression and anxiety (Pittenger and Duman, 2008; Penzes et al, 2011).  
 Dendritic filopodia are small protrusions on dendrites that can mature into 
dendritic spines. They are very motile and transient and synaptic transmission, 
particularly with glutamate, is critical in stabilizing filopodia (McKinney et al, 1999). 
Morphology changes are correlated to changes in synaptic strength (Maletic-Savatic et al, 
1999; Toni et al, 1999; Yuste and Bonhoeffer, 2001). Morphology changes that occur 
post-LTP have been shown to involve larger spine heads and shorter spine necks which 
results in an increase in current into the spine and faster calcium storage in the spine 
(Yuste and Bonhoeffer, 2001). 
 Changes in dendritic spines of neurons in the hippocampus can be stimulated by a 
variety of factors, including hormones like estradiol and progesterone as well as other 
factors such as exercise and restricting calorie intake (Gould et al, 1990; Woolley et al, 
1990; Stranahan et al, 2009). Specific changes to dendritic spines include spine shape, 
density and number and these morphological changes result in functional changes due to 
dendritic spines being a site of neurotransmission (Woolley et al, 1990). All of these 
aspects of dendritic morphology have been shown to change in response to leptin.  
 During development, leptin plays a role in axon projection growth from the 
arcuate nucleus of the hypothalamus to the paraventricular nucleus and in vitro, leptin has 
been shown to support the growth of neurites, any projection from a neuronal cell body 
(Bouret et al, 2004). Leptin can also increase neurite growth in the hypothalamus and 
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cerebellar purkinje neurons (Bouret et al, 2004; Oldreive et al, 2008). These data from 
outside the hippocampus further support the role of leptin in inducing morphology 
changes (Oldreive et al, 2008). Leptin increases spine density in vivo and in vitro, slices 
and cultures, respectively (Dhar et al, 2014; O’Malley et al, 2007). This is seen with 
synapsin-1 staining of the somata and neurites after leptin was administered (O’Malley et 
al, 2007). Studies in a model of leptin signaling deficiencies show that leptin receptor 
function is critical for normal dendritic spine density, as these animals had less dense 
spines than controls in areas CA1 and CA3 of the hippocampus (Dhar et al, 2014).  
 In order to assess whether leptin may effect dendritic spines that could lead to 
functional synapse formation, hippocampal cell cultures were used to show that leptin 
application increased spine density. Dendritic spines themselves can also be matured in 
the presence of leptin and a leptin-deficient state results in smaller spine density, 
supported by other studies in another model (O’Malley et al, 2007; Dhar et al, 2014). In 
the same set of experiments, it was determined that excitatory transmission is critical in 
these morphological changes, mediated through NMDA receptors but not AMPA 
receptors (O’Malley et al, 2007).   
 Dendritic filopodia have been shown to be affected by leptin application 
(O’Malley et al, 2007). In the presence of leptin, neurons saw a significant increase in 
dendritic filopodia number, or density (O’Malley et al, 2007). To determine whether or 
not leptin receptor activation was required for the increase in density, siRNA was used to 
reduce the expression of the leptin receptor. It was found that the density of the dendritic 
filopodia decreased as the leptin receptor expression decreased, implying that the leptin 
receptor was required for the increase in density of filopodia (O’Malley et al, 2007). 
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Leptin can also increase the formation of new extensions on the filopodia, as seen by the 
appearance of growth cones (O’Malley et al, 2007). Additionally, leptin can influence re-
organization of actin protein cytoskeleton in neurons from the base of the dendrite to the 
filopodia, changes in the actin cytoskeleton being critical for any change in morphology 
(O’Malley et al, 2007; O’Malley et al, 2005).  
 Motility of the dendritic filopodia was also increased in the presence of leptin 
(O’Malley et al, 2007). Leptin exposure also resulted in the lengthening of neurites that 
were similar to filopodia. Although leptin has been shown to signal using the PI3K 
pathway for fast actions, any effects that leptin has on dendritic morphology were found 
to be mediated through MAPK signaling (O’Malley et al, 2007). It was suggested that 
STAT3 signaling was most likely not involved in the fast morphology changes seen 
during the experiments (O’Malley et al, 2007). 
 Morphology changes in dendritic spines and synaptogenesis, the generation of 
new synapses, are closely linked. The early stages of synaptogenesis are marked by 
motility of dendritic filopodia, and this has been proposed as being how new synapses are 
formed (Ziv and Smith, 1996). A study supports this by showing that the effect of leptin 
that results in increasing dendritic spine filopodia number and motility leads to the 
formation of new and active synapses (Dhar et al, 2014). Dendritic filopodia are involved 
in synaptogenesis such that they can initiate new synaptic contacts (Ziv and Smith, 1996). 
One study has shown that spine density and levels of synaptic proteins synapsin-1-
positive puncta increase after exposure to leptin (O’Malley et al, 2007). This would 
support the idea that leptin can increase synaptic contacts and therefore synaptogenesis. 
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MAPK signaling is required for these morphology changes but not PI3K signaling 
(Harvey, 2013; O’Malley et al, 2007).  
 Leptin influences morphology in a similar manner to how LTP results in 
morphology changes (Maletic-Savatic et al, 1999). Spine density, filopodia number and 
motility increases both with leptin and after LTP occurs (Dhar et al, 2014; O’Malley et al, 
2007). This morphological evidence shows that leptin can influence the dendritic spines 
and filopodia, a major site of excitatory input to a post-synaptic neuron which can alter 
the neuron’s overall excitability in addition to promoting synaptogenesis and may be an 
important component of leptin-induced LTP (Maletic-Savatic et al, 1999). 
 
2.2.1 NEUROGENESIS 
 Cell proliferation, the addition of new cells, and neurogenesis, the addition of new 
neurons, may also be considered a morphological change indicating synaptic plasticity. 
Before the birth of an organism, neurogenesis takes place in the ventricular zone and after 
birth, takes place in the subgranular zone (Schlessinger et al, 1975; Altman and Bayer, 
1990; Schoenfeld and Gould, 2012; Leuner and Gould, 2010; Altman 1962; Altman and 
Das 1967; Kaplan and Hinds 1977; Gould et al, 1999b). 
 Many factors can effect neurogenesis and how long new neurons are able to 
survive, such as stress and psychotropic drugs like antidepressants (McEwen, 1999; 
Gould et al, 1997; Duman et al, 2001; Dranovsky and Hen, 2006). For example, acute 
stress decreases cell survival as compared to social defeat stress and chronic stress that 
can decrease cell proliferation, a different stage of neurogenesis (Gould et al, 1997; 
Gould et al, 1998; Schoenfeld and Gould, 2012; Yap et al, 2006). Other factors such as 
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aging and glucocorticoids decrease cell proliferation (Kuhn et al, 1996; Seki and Arai, 
1995; Cameron and Gould, 1994; Cameron and McKay, 1999), while learning (Gould et 
al, 1999a), exercise and seizures (Parent et al, 1997) increase neurogenesis (van Praag et 
al, 1999). There are even sex differences, if rats are isolated after chronic shock, male rats 
show less survival of new neurons whereas female rats increase survival of new neurons 
(Westenbroek et al, 2004). Interestingly, exposure to a predator odor decreases cell 
proliferation in male rats but not female rats (Falconer and Galea, 2003). In addition to 
these factors, leptin can also influence neurogenesis.  
 The effects of leptin on all three stages of neurogenesis has been assessed and it 
has been found that leptin can influence both the cell proliferation and differentiation of 
progenitor cells (Garza et al, 2008). Adult mice were treated with different doses of leptin 
and injected with BrdU, a marker for proliferating cells. Progenitor cells were collected 
and analyzed for presence of the leptin receptor mRNA. After 2 weeks of treatment with 
leptin and BrdU, there was a significant increase of BrdU-labeled cells in the dentate 
gyrus of the hippocampus compared to vehicle-treated controls (Garza et al, 2008). This 
shows that leptin increases cell proliferation. After 28 days, to allow new cells to 
differentiate, the leptin-treated group still had significantly more BrdU-labeled cells than 
controls. Cells were double-labeled with antibodies against either NeuN and GFAP and 
BrdU to discern between new neurons and new glial cells, respectively. This revealed 
that in the leptin treated group, most cells were NeuN-positive, confirming the new cells 
were neurons, with only a small percentage colocalization with BrdU and GFAP. 
Interestingly, the proportion of double-labeled BrdU and NeuN cells vs GFAP-BrdU 
labeled cells did not differ between the vehicle-treated control group and leptin-treated 
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group. To show the effects of leptin on cell survival, animals were injected with BrdU 
pre-leptin treatment, however there was no difference between the number of surviving 
cells with the vehicle and leptin treated groups. Immunocytochemistry in cultured 
progenitor cells indicated that both the leptin receptor mRNA and protein were present 
(Garza et al, 2008). This data shows that leptin does not have a significant effect on cell 
differentiation or cell survival but instead enhances the first stage of neurogenesis, cell 
proliferation. 
 To further investigate the role of leptin in cell proliferation, studies were 
completed in adult hippocampal progenitor cultures. The effects of leptin on cell 
proliferation in culture was dose-dependent, a dose of 1nM resulted in the highest amount 
of BrdU-labeled cells and higher doses had no effects, reinforcing other studies that 
found an inverted U shape for maximum responses (Garza et al, 2008). These 
experiments in cultures to assess the effects of leptin on differentiation and survival 
showed similar results as the in vivo studies as no differences were found between leptin 
and control groups (Garza et al, 2008). In determining which signaling pathways leptin 
activated in progenitor cells in culture, it was found that phosphorylation of Akt of the 
PI3K pathway and STAT3 of the JAK2/STAT3 pathway were increased after 15 minutes 
of treatment with leptin (Garza et al, 2008). There was no significant change in the 
phosphorylation of ERK after leptin treatment, indicating that leptin activated 
JAK2/STAT3 and PI3K signaling but not MAPK signaling (Garza et al, 2008). Blocking 
Akt and STAT3 with an inhibitor resulted in significantly less BrdU-labeled cells treated 
with leptin, reinforcing the data that leptin utilizes PI3K and JAK2/STAT3 for signaling 
in progenitor cells of the dentate gyrus in the hippocampus (Garza et al, 2008).  
 
25 
 Leptin not only affects cell proliferation but has also been shown to have a rescue-
effect on neurogenesis after a chronic unpredictable stress (CUS) paradigm. Stress has 
been shown to substantially decrease neurogenesis in the dentate gyrus and CUS has been 
shown to cause depressive-like symptoms in animals (Jayatissa et al, 2006). 
Glucocorticoids can also decrease neurogenesis while antidepressant medications 
increase neurogenesis (Dranovsky and Hen, 2006). A series of experiments subjecting 
rats to chronic unpredictable stress for 21 days revealed deficits in neurogenesis (Garza et 
al, 2013). BrdU labeling after stress revealed that CUS had a reducing effect on the 
number of BrdU labeled cells in the dentate gyrus (Garza et al, 2013). Leptin was then 
administered to CUS animals for 2 weeks after the entire 21-day CUS paradigm. 
Neurogenesis was analyzed by counting BrdU-labeled cells in the dentate gyrus and it 
was found that leptin treatment significantly increased the amount of BrdU-labeled cells 
when administered chronically (Garza et al, 2013). The new cells were mostly neurons, 
as seen by double-labeling with NeuN and BrdU (Garza et al, 2013). Cell survival was 
analyzed 28 days later and the number of BrdU-labeled cells that survived with leptin 
treatment was more than with CUS stress alone; and CUS animals showed lower 
numbers of surviving cells than the non-CUS and non-leptin treated groups (Garza et al, 
2013). Body weight was decreased in all groups subjected to CUS and leptin treatment 
groups saw additional body weight reductions, a normal result of stress and leptin 
treatment (Garza et al, 2013). This data has shown that leptin can almost completely 
reverse the deficits in neurogenesis after a CUS model.  
 It has been shown that rats subjected to chronic stress show anhedonia and a 
decrease in dentate gyrus neurogenesis (Jayatissa et al, 2006). The depressive-like 
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symptoms have been alleviated by the antidepressant escitalopram, administered 
systemically via an intraperitoneal (i.p.) injection, and neurogenesis was restored 
(Jayatissa et al, 2006). Antidepressants seem to inhibit the stress effects (Dranovsky and 
Hen, 2006). This data mirror the effect of leptin on neurogenesis, as demonstrated by an 
experiment with chronic unpredictable stress and leptin treatment. This suggests that 
leptin has an antidepressant- like effect possibly involving the restoration of neurogenesis 
(Jayatissa et al, 2006; Garza et al, 2013). 
 Neurogenesis is an important aspect of synaptic plasticity because new neurons in 
the dentate gyrus have been shown to produce LTP more readily than more mature 
neurons (Snyder et al, 2001). Under normal physiological conditions, granule neurons 
have inhibitory GABAergic inputs to control their excitation (Snyder et al, 2001). It was 
proposed that new neurons had much less GABAergic input that would inhibit them, 
making activation of these neurons easier. A study has shown the presence of two 
different types of LTP in the medial perforant pathway, one type presumably from new 
neurons and another from old neurons (Snyder et al, 2001).  The first, small current LTP 
was induced in hippocampal slices in artificial cerebrospinal fluid (ASCF) after tetanus 
whereas a second, much larger LTP occurred after picrotoxin was added (Snyder et al, 
2001). Additionally, the small LTP was blocked by ifenprodil, an NR2B NMDA receptor 
subtype antagonist in contrast to the larger LTP that was not blocked by ifenprodil. These 
results indicate two sets of neuron populations that react differently and have different 
amplitudes of LTP, not just two different synapses due to the GABAergic input. This 
study shows the importance of neurogenesis and how new neurons may play a role in 
learning (Moser, 1996).  
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 Collectively, leptin has a clear enhancement of cell proliferation both in vivo and 
in cultures and signals with both the JAK/STAT and PI3K signaling pathways for these 
effects (Garza et al, 2008). Leptin also has a rescue effect of the reduction of 
neurogenesis in a model of chronic unpredictable stress and has striking neurogenesis-
restoring abilities similar to the effects of an antidepressant (Garza et al, 2013). In 
addition to these effects on neurogenesis, leptin can also alter behavior. 
 
2.3 LEPTIN & BEHAVIOR 
 Behavioral tests allow for the study of overall effect on function as a result of 
some stimulus, such as leptin. There are many behavioral tests to assess specific types of 
learning and memory, for example the Morris Water Maze for spatial learning and 
memory, the novel object recognition test to assess hippocampal-dependent memory and 
passive shock avoidance to test emotional learning and memory. The Morris Water Maze 
is a hippocampal-dependent, spatial learning and memory test. The test consists of a 
circular tank of water with four quadrants and an opaque, submerged platform in one 
quadrant. The platform remains in the same quadrant for the duration of the test. Training 
consists of placing the animal in the water and the animal swims until it finds the 
platform. Swimming time, distance and speed are all measured. On test day, the platform 
is removed and the time and distance taken to find the location where the platform was, 
the goal area, is measured. Shorter swimming times and distances indicate better 
performance and speed is measured to determine whether or not all groups of animals are 
operating with the same locomotor activity (Oomura et al, 2006).  
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 The novel object recognition tests for hippocampal-dependent working memory 
performance with a new object and old object. The animal is placed in a chamber or box 
and is allowed to explore or habituate a day before testing. Training consists of the 
chamber containing of two of the same novel objects and the animal is allowed to explore 
for a certain amount of time, for example 10 minutes. Next, the animal is reintroduced to 
the same chamber and with two objects, one being a previously explored object and one 
being entirely new. The following aspects are analyzed: time and frequency spent 
exploring each object as well as other behaviors such as grooming and rearing. The 
discrimination index measures recognition memory: total time spent with new object/total 
time of object exploration (Greco et al, 2010). More time spent with the new object 
indicates better performance in terms of working memory.  
 The passive avoidance task consists of a box with light and dark sections 
separated by a guillotine door. The animal is placed in the light section for some amount 
of time then the door opens and the animal is allowed to move to the dark section. After 
this occurs, the door is closed and a footshock is delivered. Latency, the delay in entering 
the dark section, is measured and a longer latency is indicative of a better performance in 
emotional learning (Oomura et al, 2006). 
 Leptin treatment has been shown to elicit differences compared to controls in 
many behavioral tests. Leptin injections directly into the hippocampus improves spatial 
and emotional learning, memory and retention as determined by several behavioral 
analyses (Harvey, 2007; Farr et al, 2006; Oomura et al, 2006). For example, leptin 
improves performance in the passive shock avoidance and MWM behavioral tests dose-
dependently (Oomura et al, 2006). Different doses of leptin result in improved memory 
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performances again in an inverted U with the lowest and highest doses of leptin had 
longer swimming times, swimming distances, and less time spent in the area of the 
platform. More time spent in the area where the hidden platform was previously, shorter 
swimming distances and times indicate better memory performance. This dose-dependent 
effect is similar to what was seen with leptin in other experiments with leptin having 
dose-dependent effects on LTP, CaMKII activity and cell proliferation (Garza et al, 2008; 
Oomura et al, 2006; Wayner et al, 2004). 
 The passive avoidance shock test, designed to test emotional learning, showed an 
inverted-U dose response to leptin. Using the same doses as in the Morris Water Maze, 
middle doses of leptin, 5 u g/kg and 50 u g/kg, resulted in longer latencies to step down, 
indicative of better performance (Oomura et al, 2006). These behavioral differences were 
unrelated to changes in locomotion or changes in pain sensitivity, as behavioral response 
to a hot-plate was similar among all groups. 
 Another study found similar findings, i.p. injected leptin resulted in significant 
increased performance in the Morris Water Maze compared to vehicle- injected controls 
(Rasi et al, 2007). In addition, medium doses had the most significant increase in spatial 
memory, a consistent finding between several groups (Rasi et al, 2007; Oomura et al, 
2006; Garza et al, 2008). Possible reasons behind the dose-dependent effect of leptin 
increasing spatial learning and memory as well as cell proliferation in neurogenesis may 
be related to the leptin-activated potassium channel (Spanswick et al, 1997; Shanley et al, 
2002). This channel opens after prolonged excitation and may open with higher doses of 
leptin, hyperpolarizing the membrane. It is also possible that low doses of leptin may not 
be effective due to the dose being too small for effects to be seen. 
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 To further support leptin improving behavioral testing performance, 
improvements have also been seen in the T-maze footshock avoidance and the one trial 
step down inhibitory avoidance test for memory in mice after leptin was administered 
bilaterally into the hippocampus (Farr et al, 2006). In outbred, CD-1 rats leptin 
administration before testing was shown to enhance performance in the T-maze 
footshock avoidance and the one trial step down inhibitory avoidance tests to assess 
memory processing. In contrast, if leptin was given after training, memory retention was 
not improved. In year-old SAMP8 mice, a mouse model of Alzheimer’s Disease, 
intrahippocampal injections of leptin improved performance in the T-maze footshock 
avoidance test (Farr et al, 2006). Similar results were also found in year-old SAMP8 mice 
in the step down inhibitory avoidance test, where a longer latency to step down is 
indicative of a better performance.  
 In a series of experiments subjecting rats to chronic unpredictable stress for 21 
days paired with the open field test and sucrose preference test revealed several deficits 
(Garza et al, 2013). Rats subjected to the CUS paradigm for 21 days had less exploratory 
behaviors in open field, anhedonia behaviors in sucrose preference and more immobility 
time in forced swim (Garza et al, 2013). These results indicate depressive-like 
characteristics. Leptin was then administered to CUS animals for 2 weeks after the entire 
21-day CUS paradigm. Although there was no change in exploratory behaviors in open 
field, leptin reversed the anhedonia seen in the sucrose preference test in CUS animals 
and leptin treatment decreased immobility time, an indicator of depressive-like behaviors 
(Garza et al, 2013). Body weight was decreased in all groups subjected to CUS and leptin 
treatment groups saw additional body weight reductions (Garza et al, 2013). This 
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suggests that leptin has an antidepressant- like effect in reversal of depressive-like 
symptoms like anhedonia and immobility time in the forced swim test (Jayatissa et al, 
2006; Garza et al, 2013). 
 In addition to the studies described above, models of leptin resistance or 
deficiency have also provided insight into the role of leptin in relation to the regulation of 
hippocampal synaptic plasticity. Experimental models of disrupted leptin signaling 
exhibit deficits in hippocampal synaptic plasticity thereby providing further evidence for 
a key role of leptin in mediating structural and functional activities of the hippocampus. 
 
2.4 ANIMAL MODELS OF LEPTIN DYSFUNCTION 
 There are several models of leptin resistance or deficiency to demonstrate a 
dysregulated leptin state and the resulting changes in synaptic plasticity. One model is the 
Zucker rat which has a point mutation in its leptin receptors that results in impairments in 
signaling (Zucker and Zucker, 1961; Clark et al, 1983). The db/db mouse has malformed 
leptin receptor transcript which shortens the intracellular domain used for signaling, 
resulting in the inability to form a working leptin receptor (Chen et al, 1996; Chua et al, 
1996). In both the Zucker rat and db/db mouse, leptin is still synthesized but normal 
signaling with the leptin receptor cannot occur (Li et al, 2002). In db/db animals, there is 
no change in mRNA expression for the microvessel BBB short isoform ObRa used for 
leptin transport and db/db mice show normal transport of leptin across the BBB (Hileman 
et al, 2002). The ob/ob mouse is leptin deficient through genetic modification but has 
normally functioning leptin receptors (Hummel et al, 1966). The diet-induced obese 
(DIO) animal model is fed a high-fat diet to achieve metabolic parameters associated 
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with obesity. The obesity and hyperphagic phenotype of the Zucker rat, db/db and ob/ob 
mice also appears with lesioning of the hypothalamus, demonstrating the importance of 
the hypothalamus in regulation of feeding and energy expenditure (Baylis et al, 1996). 
These models also give evidence that leptin also has a role in reproduction because ob/ob 
and db/db mice both have abnormalities with puberty, fertility and lactation (Sainsbury et 
al, 2002c; Donato et al, 2011).  
 The physiology of each of these models includes: obesity, leptin resistance or 
leptin deficiency, insulin resistance, increased body fat, and dyslipidemia, and endocrine 
dysfunction (Zucker and Antoniades, 1972; Pelleymounter et al, 1995; Halaas et al, 1995; 
Coleman et al, 1978; Ahima et al, 1996). These models demonstrate the importance of 
leptin in metabolic functions including glucose homeostasis, as administering leptin to 
the brains of ob/ob mice corrects glucose imbalances inherent in the ob/ob model 
(Asilmaz et al, 2004). And importantly, decreasing body weight does not entirely fix the 
glucose imbalances in these animals, showing that diet-induced obesity and obesity itself 
are not the only cause of the metabolic imbalances (Flak and Myers, 2015; Pelleymounter 
et al, 1995; Wyse et al, 1970; Schwartz et al, 1996). For these reasons, the Zucker rat, 
db/db mice ob/ob mice, and DIO rodents are often used as models of obesity, metabolic 
syndrome and type 2 diabetes mellitus.  
 
2.5 ANIMAL MODELS AND SYNAPTIC PLASTICITY DEFICITS 
 Deficient leptin function, whether through the receptor or the circulating peptide 
itself, has several effects on synaptic plasticity in the hippocampus. Due to the fact that 
Zucker rats and db/db mice both have impairments in the leptin receptor, they both show 
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very similar synaptic plasticity impairments. One study investigated the differences 
between LTP, LTD and CaMKII activity Zucker rats, db/db mice and lean controls. It 
was found that hippocampal slices from fatty Zucker rats exhibited a lack of LTP in area 
CA3 with and without bath application of leptin and this LTP is normally evoked in 
control Zucker rats (Li et al, 2002). Experiments determining LTD in fatty Zucker rats 
showed similar impairments; fatty Zucker rats did not elicit LTD with or without leptin in 
a dose that normally would elicit LTD in controls. GABA and Quis were applied to slices 
and corresponding hyperpolarization was seen, however leptin application had no effect, 
showing that fatty Zucker rats were not responding to leptin normally (Li et al, 2002). 
Hippocampal slices from db/db mice were assessed for LTP and LTD qualities and it was 
found that db/db mice showed an inability to maintain LTP with or without leptin in 
solution. LTD was unable to be evoked and just as with Zucker rats, db/db mice have 
diminished LTP and LTD compared to controls. Calcium-independent CaMKII activity 
was assayed in both Zucker rats and db/db mice. Fatty Zucker rats showed significantly 
less CaMKII activity while db/db mice had no difference compared to controls (Li et al, 
2002). Mechanistically, this may indicate deficits in the enzyme that could be causing the 
impairments in LTP and LTD. Other studies show impairments in the ability of fatty 
Zucker rats to exhibit normal LTP (Moult et al, 2010; Gerges et al, 2003). 
 Morphological abnormalities are also found in animal models with dysfunctional 
leptin. Density of excitatory and inhibitory synapses in ob/ob mice differ from control 
mice and interestingly, systemic leptin administration will normalize these changes in 
density in approximately 6 hours (Harvey, 2013; Pinto et al, 2004). Both db/db and ob/ob 
animals have been shown to have smaller brain weights, demonstrating additional 
 
34 
structure deficits (Ahima et al, 1999). Both animal models also have immature synaptic 
proteins and decreased myelin as well as fewer synaptic markers such as SNAP-25, 
syntaxin-1, and GAP, implying fewer synapses (Ahima et al, 1999). Administration of 
leptin to the ob/ob and db/db animals resulted in an increase in brain weight and 
corrected the reductions in synaptic-associated proteins SNAP-25, syntaxin-1 and GAP 
levels (Ahima et al, 1999). 
 Studies in db/db mice show that leptin receptor function is critical for normal 
dendritic spine density, as db/db mice had less spine density than controls in areas CA1 
and CA3 of the hippocampus (Dhar et al, 2014). To further support this, db/db mice have 
been shown to have decreases in spine density in the dentate gyrus hippocampus in vivo 
and DIO models have smaller dendritic spine densities in area CA1 (Stranahan et al, 
2009; Stranahan et al, 2008c). DIO mice also show impaired transport of leptin across the 
BBB compared to lean controls (Banks et al, 2003). This has been shown to be an 
decreased ability of the BBB to transport leptin, not just saturation of the leptin transport 
system (Banks et al, 2003). In lentivirus-mediated insulin receptor downregulated (IRAS) 
rats that exhibit an obese phenotype, a presynaptic protein and postsynaptic protein, 
synaptophysin and PSD-95 respectively, were found to have less organized PSD-95 and 
clustered SYN protein, implying a structural change (Grillo et al, 2011). These studies 
show the effect of leptin on brain weight, synaptic proteins and myelination and gives 
evidence that leptin is involved in brain structure and morphology. 
 Fatty Zucker rats have been shown to show less neuronal differentiation, as 
opposed to glial cell differentiation, part of the stages of neurogenesis and both fatty 
Zucker rats and db/db mice show less cell proliferation in the hippocampus (Yi et al, 
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2009). DIO rodents also show impairments in neurogenesis, specifically in cell survival 
(Lindqvist et al, 2006). 
 Behavioral analyses of Zucker rats and db/db mice have also shown that these 
animals have learning and memory impairments. Fatty Zucker rats had longer swimming 
distances and had less passes through the platform area in the probe test section of the 
Morris Water Maze compared to their lean counterparts (Li et al, 2002). Swimming 
speeds were no different between groups, indicating that Zucker rats were able to swim 
normally. The db/db mice were also subjected to the Morris Water Maze and there were 
differences in swimming distances between groups at the fourth block and db/db mice 
had less passes through the platform area. The groups had similar swimming speeds, 
indicating swimming ability was similar between groups. These behavioral data indicates 
that both Zucker rats and db/db mice have a decrease in spatial memory.   
 Another behavioral assessment, the go/no-go variable interval delayed alternation 
task (VIDA) has shown additional cognitive impairments in fatty Zucker rats. In the 
VIDA test, animals are placed in a Skinner box that contains a lever that, when pressed, 
allows food to enter a feeder next to it. Once animals were food restricted, they were 
trained to lever press for food. The VIDA test had trials that gave food when the lever 
was pressed (go trials) alternating with trials that did not give food (no-go trials). The 
time between each trial, the intertrial interval, would vary from 0 to 80 seconds. The fatty 
Zucker rats and lean Zucker rats had no differences in training with the lever or in 
learning the alternation test when there was 0 seconds of delay between go and no-go 
trials (Winocur et al, 2005). Latency to first leverpress was assessed in order to insure 
that each group could physically do the task. As the intertrial interval increased in time, 
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both groups showed a decline in ability however fatty Zucker rats had significantly worse 
performance than lean Zucker rats, indicating memory deficits at the longer intertrial 
interval as shown by the shorter latency on no-go trials. This deficit indicates an 
impairment of hippocampal-dependent memory and not a lack of motivation or ability 
(Winocur et al, 2005). 
 In a study with DIO rats that showed impairments in performance in the Morris 
Water Maze, it was found that an 8-week exercise intervention improved cognitive 
performance (Cheng et al, 2016). The IRAS rat model, in addition to being obese are also 
hyperleptinemic and hypertriglyceridemic and have shown hippocampal-dependent 
behavioral deficits (Grillo et al, 2011). The IRAS rats had deficits in contextually 
conditioned freezing, specifically less freezing behavior during retention, compared to 
controls (Grillo et al, 2011).  
 These studies in animal models of abnormal leptin have shown deficiencies in 
LTP, LTD, CaMKII activity, neurogenesis, morphology as well as learning and memory. 
In addition to these metabolic disorders, animal models of leptin dysfunction also show 
depressive and anxiety- like deficits, demonstrating that leptin plays a role in cognitive 
disorders. 
 
2.6 LEPTIN IN DEPRESSION, ANXIETY & STRESS 
 In addition to electrophysiological, morphological and hippocampal-dependent 
memory deficits, as seen by the VIDA and Morris Water Maze tests, db/db mice show 
cognitive impairments and depressive-like behaviors (Sharma et al, 2010; Moult et al, 
2010; Gerges et al, 2003; Ahima et al, 1999; Winocur et al, 2005; Li et al, 2002). 
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Anxiety-like behaviors are seen in some studies and not in others, although this may be 
due to different behavioral testing, species or strains (Sharma et al, 2010; Liu et al, 2010).  
 Both young and adult db/db mice show impairments in the forced swim test, a 
behavioral test for depressive-like behaviors (Sharma et al, 2010). In a study investigating 
depressive-like and anxiety- like features in young and older db/db mice, control mice and 
db/db mice were separated into groups of juvenile 5-6 weeks old and adult, 10-11 weeks 
old (Sharma et al, 2010). Extensive behavioral testing was completed, including the 
forced swim test, pre-pulse inhibition test, elevated plus maze, open field and Y-maze 
test. The pre-pulse inhibition test consists of mice being placed in startle chambers 
followed by a white noise that is sounded five times and is designed to measure 
psychosis-like behavior. The Y-maze tests working memory by using exploratory 
behavior, mice placed in intersection of Y and tested to see how many times the mouse 
entered an arm, entering into 3 different arms after each other referred to as an 
alternation.  
 In the forced swim test, both young and old db/db mice showed longer immobility 
times, indicating behavioral despair analogous to a depressive-like behavior (Sharma et 
al, 2010). During the pre-pulse inhibition, normal startling was seen in young animals but 
not old, adult db/db mice had lower percent pre-pulse inhibition (PPI) compared to lean 
controls. In the elevated plus maze, same distance was traveled in the open arms of the 
maze by db/db mice compared to controls but juvenile and adult db/db mice spent 
significantly more time in the open arms, indicating an anti-anxiety- like behavior 
(Sharma et al, 2010). In the open field test, both groups of db/db mice showed less 
activity counts for basic and fine movement than controls but all groups spent more time 
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exploring the periphery of the open field instead of the center area, with no difference 
between db/db and controls in proportion of time spent in the periphery versus the center 
(Sharma et al, 2010). The Y-maze test showed that adult db/db mice had less arm entries 
and alternations but no change in percent Y-maze scores, showing no significant 
difference in working memory between adult db/db mice and age-matched controls. 
These data show that in many different behavioral tests, adult db/db mice in particular 
show depressive-like and psychosis-like behaviors although db/db mice showed less 
anxiety- like behaviors than lean controls with no differences in working memory 
between groups (Sharma et al, 2010).  
 Additional studies looking at depressive-like and anxiety-like behaviors were 
completed to focus on the role of the hippocampal leptin receptors in these behavioral 
states. Deletion of leptin receptors in the hippocampus, using the targeted Cre/lox system, 
resulted in anhedonia in the sucrose preference test and depressive-like behaviors in the 
tail suspension test (Guo et al, 2012). Leptin or vehicle was administered via an i.p. 
injection to leptin receptor knockout mice and wild type mice and then the forced swim 
or tail suspension tests were conducted. Leptin receptor knockouts treated with saline 
showed more immobility time than controls and leptin significantly decreased immobility 
time in wild type mice while having no effect on leptin receptor knockout mice. 
Additionally, the sucrose preference test showed leptin knockouts had a much lower 
preference for the sucrose solution than wild-type controls (Guo et al, 2012). Anxiety- like 
behaviors were also analyzed using the elevated plus maze and open field tests however 
there were no differences between leptin receptor knockouts and controls, similar results 
to another study looking at anxiety- like behaviors in db/db mice (Guo et al, 2012; Sharma 
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et al, 2010). These data shows that leptin receptor knockout mice exclusively in the 
hippocampus were unable to have their depressive-like behavior reversed when leptin 
was administrated while leptin resulted in less depressive-like behavior in wild type mice, 
indicating that leptin can result in antidepressant effects that are mediated through 
hippocampal glutamatergic neurons.  
 In a study looking at the effects of leptin and fluoxetine administration on several 
tests for anxiety- like behavior, it was found that leptin is anxiolytic (Liu et al, 2010). 
Male C57BL/6J mice, with normal leptin and leptin receptor function, were given either 
i.p. leptin or fluoxetine injections and then subjected to the tail suspension and forced 
swim tests for depressive-like behavior. It was found that both leptin and fluoxetine 
significantly decreased immobility time compared to vehicle controls, immobility as an 
indicator of behavioral despair or depressive-like symptoms. Anxiety-like behaviors were 
assessed in a similar fashion, using the elevated plus maze. It was found that following an 
i.p. leptin injection, leptin administration resulted in increased open arm time and the 
number of entries into the open arms (Liu et al, 2010). Both time in the open arms and 
number of open arm entries indicate an anti-anxiety- like effect. Interestingly, the lower 
dose of leptin did not result in these anxiolytic effects and fluoxetine decreased open arm 
entries and open arm time. The social interaction test was also completed to assess social 
behavior and leptin injection resulted in an increase in the total social interaction time, 
compared to controls (Liu et al, 2010). Additionally, leptin injection resulted in less time 
spent grooming, a function that can indicate anxiety following a stressful event. 
Interestingly, neither leptin nor fluoxetine resulted in any significant anxiolytic reaction 
in the open field test, similar to other studies that have found no significant effect of 
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leptin in the open field test (Liu et al, 2010; Guo et al, 2012; Sharma et al, 2010). This 
may imply that leptin is able to have anxiolytic effects in certain tests of anxiety and so 
perhaps leptin may play a role in particular types of anxiety. These data also collectively 
show how leptin even plays a role in social interaction and social anxiety.  
 In contrast to studies showing that depressive-like behaviors in ob/ob mice or 
normal animals can be alleviated by leptin administration, diet-induced leptin resistant 
models show the opposite. Depressive-like behaviors in diet-induced obese (DIO) mice 
and control-diet mice given a leptin injection were analyzed with the forced swim test. 
After the leptin injection, control diet animals had a lower immobility time, indicating 
less depressive-like behaviors (Yamada et al, 2011). Conversely, in the DIO mice, 
immobility time was longer compared to controls and there was no difference after leptin 
injection. In ob/ob mice, however, leptin injection decreased immobility time indicating 
less behavioral despair and an antidepressant-like effect of leptin (Yamada et al, 2011). 
DIO mice showed not only more depressive-like behaviors but also no response to the 
antidepressant-like effects of leptin. There was also no change in locomotor activity, 
indicating that body mass had no effect on swimming (Yamada et al, 2011).  
 Another test of depressive-like behaviors, the sucrose preference test, showed that 
DIO mice had a much lower preference for sucrose water than controls (Yamada et al, 
2011). Levels of c-Fos, a marker of neuronal activity, were determined in the 
hippocampus after leptin injection and it was found that in control-diet mice, c-Fos 
immunoreactive cells increased significantly post-leptin injection, indicating an increase 
in activity in this area but no such activation was seen in DIO mice (Yamada et al, 2011). 
Collectively, this data show that diet-induced obese mice and ob/ob mice show 
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depressive-like behaviors and leptin has an antidepressant- like effect in control-diet mice 
and ob/ob mice but not DIO mice. DIO mice do not have any genetic modifications and 
therefore could have a more complicated dysregulated metabolic system that could 
explain the differences in leptin treatment between DIO mice and ob/ob mice.  
 Leptin administration has been shown to play a role in stress. Chronic 
unpredictable stress and chronic social defeat are two models that have been shown to 
produce depressive-like behaviors in rats (Lu et al, 2005). The role of leptin in the 
alleviation of depressive-like symptoms after CUS and chronic social defeat were 
assessed. Depressive-like symptoms were measured using the forced swim test for 
despair and sucrose preference. CUS resulted in lower than control plasma leptin levels 
and higher corticosterone levels (Lu et al, 2005). Peripheral leptin administration 
corrected deficiencies in sucrose preference test after CUS and interestingly, leptin 
administration to non-stressed rats had no effect on the sucrose preference outcome (Lu 
et al, 2005). In the forced swim test, leptin administration resulted in a decrease in 
immobility time and an increase in swimming time, immobility time indicating 
behavioral despair, or a depressive-like phenotype (Lu et al, 2005). No effect of leptin on 
corticosterone was seen, indicating that leptin was not affecting the stress response. 
Amount of Fos immunoreactive neurons were measured in areas CA1, CA3 and the 
dentate gyrus and more activation was seen in leptin animals than saline controls (Lu et 
al, 2006). It is suggested that the hippocampus may then be a target for antidepressant-
like effects by leptin (Lu et al, 2006).  
 To further assess the idea that the hippocampus is an area for antidepressant- like 
effects, leptin was injected directly into the hippocampus. Leptin administration resulted 
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in decreased immobility time and increased swimming in the forced swim test, very 
similar to the results of systemic leptin administration (Lu et al, 2006; Liu et al, 2010). To 
see whether the hypothalamus would have similar effects as injection into the 
hippocampus, leptin was directly injected into the hypothalamus. However, no effects on 
the forced swim test immobility time or swimming time were seen, as compared to 
control and only lower body weights were seen after 1-2 days (Lu et al, 2002). This 
would imply that the hippocampus is critical in mediating the ability of leptin to result in 
antidepressant-like effects. This comprehensive study shows that leptin plays a critical 
role in the hippocampus in alleviating depressive-like behaviors, as seen by the the 
sucrose preference and forced swim tests. Circulating plasma leptin was shown to 
decrease during chronic stress and was accompanied by depressive-like behaviors. The 
direct injection or indirect systemic injection of leptin normalized these depressive-like 
behaviors and this appears to have been mediated by the hippocampus (Liu et al, 2010; 
Lu et al, 2006).  
 Leptin, as previously discussed, increases neurogenesis in the hippocampus and 
antidepressants have also been shown to increase neurogenesis (Garza et al, 2008; Garza 
et al, 2013; Dranovsky and Hen, 2006). Chronic unpredictable stress decreases 
neurogenesis and also results in depressive-like behaviors that can be corrected by leptin 
(Lu et al, 2005; Lu et al, 2006; Jayatissa et al, 2006). This may indicate a link between 
leptin, neurogenesis and depression and perhaps some the antidepressant- like effects of 
leptin are mediated by the hippocampus, as seen by the c-Fos studies for neuronal 
activation (Lu et al, 2006; Yamada et al, 2011). 
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 Studies done in animal models looking at the relationship between leptin and 
depression also may be applicable to humans. Major depressive disorder correlates with 
low leptin levels (Jow et al, 2006; Kraus et al, 2001). One study found an inverse 
relationship between scores on tests for depression, the Hamilton Rating Scales for 
Depression (HAM-D) and Perceived Stress Scale (Lawson et al, 2012). The higher the 
score on these evaluations of depression, the lower the leptin levels. Conversely, 
schizophrenia is associated with high levels of leptin, however this could be a result of 
side effects from antipsychotic medications taken for schizophrenia (Jow et al, 2006). 
 In addition to leptin playing critical roles in depression, anxiety and stress, leptin 
has also been shown to be involved in cognitive, learning and memory deficits in 
dementia and Alzheimer’s disease which further support leptin having an important role 
in synaptic plasticity. 
 
2.7 LEPTIN & ALZHEIMER’S DISEASE 
 To support the role of leptin in cognition, learning and memory, studies in various 
models of Alzheimer’s Disease have shown improvements in memory function with 
leptin administration as well as a correlation between circulating levels of leptin and the 
disease. In addition, it has been found that high levels of leptin are protective against the 
symptoms of Alzheimer’s disease.  
  Leptin levels have been shown to be dysregulated in aged rats and in mouse 
models of Alzheimer’s disease. In humans, plasma leptin levels correlate with the 
progression of the disease, in that higher leptin levels correlated with less cognitive 
decline over a longitudinal study of four years (Holden et al, 2009). Aged rats are less 
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responsive to leptin, compared to young controls, as demonstrated by an experiment 
showing how leptin infused into young and old rats show differences percent decrease in 
food intake (Scarpace et al, 2000). Young rats showed a 50% decrease while old rats only 
showed 20%, showing that the normal effects of leptin on decreasing food intake 
mediated by the hypothalamus were not as effective in older rats (Scarpace et al, 2000). 
A decreased response to leptin in the hypothalamus in this experiment resulted in deficits 
in feeding behaviors which could possibly translate to a decreased response to leptin in 
the hippocampus with corresponding learning and memory deficits. This shows how 
leptin levels are abnormal in Alzheimer’s Disease and aging and therefore provide a basis 
to analysis the roles of leptin in cognition, learning and memory.  
 The SAMP8 mouse model of Alzheimer’s disease has learning and memory 
deficits due to an overproduction of the amyloid precursor protein and amyloid β protein, 
accumulation of amyloid β protein into amyloid plaques being one of the major hallmarks 
of the disease (Morley et al, 2000). Blocking the amyloid β precursor protein has resulted 
in memory and memory retention function improvements (Morley et al, 2000; Banks et 
al, 2001). Antibodies to β amyloid have similar increases in memory retention and 
acquisition (Morley et al, 2000). Interestingly, leptin has been shown to play a role in 
blocking amyloid β and can reverse amyloid β-induced LTP and glutamate receptor 
trafficking inhibition (Doherty et al, 2013). The SAMP8 mouse model accumulates 
amyloid β protein in many areas of the brain, in areas including the cingulate cortex, 
septum and hippocampus (Morley et al, 2000). Amyloid β has been shown to inhibit LTP 
induction and facilitate the reabsorption of glutamate receptors from the membrane in the 
hippocampus (Irving and Harvey, 2014). These animal models have shown deficits in 
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hippocampal-dependent learning (Farr et al, 2006). Both SAMP8 mice and CD-1 control 
mice were administered leptin and then subjected to the T-maze and step down inhibitory 
avoidance. SAMP8 mice given leptin saw improvements in both tests and interestingly, 
the older SAMP8 mice showed improvements at a lower dose of leptin than mice at 4 
months of age who also had less amyloid β (Farr et al, 2006). This strengthens evidence 
that leptin is able to improve memory performance, even in a model with memory 
deficits.  
 The other hallmark of Alzheimer’s Disease is the presence of neurofibrillary 
tangles that are a result of the excessive phosphorylation of tau protein (Beccano-Kelly 
and Harvey, 2012). Leptin can inhibit GSK3β activity and dose-dependently reduce tau 
phosphorylation (Freude et al, 2005; Valerio et al, 2006; Platt et al, 2016). It has been 
suggested that leptin interferes with the β amyloid production enzyme, β secretase, to 
reduce amyloid β (Beccano-Kelly and Harvey, 2011; Greco et al, 2008). Leptin could 
also act on the ApoE enzyme that then induces uptake β amyloid into neurons for 
degradation (Greco et al, 2008). Chronic leptin treatment resulted in a reduction of levels 
of amyloid β and phosphorylated tau in experiments in CRND8 mice, a model that has 
memory deficits and an Alzheimer’s disease-like pathology (Greco et al, 2010). This is 
supported by experiments in neuronal cells treated with leptin, as leptin treatment 
reduced tau phosphorylation and reduce amyloid β (Greco et al, 2008).  
 The CRND8 mouse model of Alzheimer’s Disease has also shown improvements 
in hippocampal-dependent memory tests after leptin treatment. Two memory tests were 
used, the novel object recognition test and trace fear conditioning, novel object for new 
object vs old object exploration to test recognition memory and trace fear conditioning 
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for ability to recall an negative stimulus and relate it to a particular environment (Greco 
et al, 2010). These hippocampal-dependent memory tests showed that leptin treated 
CRND8 mice performed almost identically to wild type mice whereas CRND8 mice 
treated with saline performed significantly worse (Greco et al, 2010). This shows that the 
CRND8 mice treated with chronic leptin were able to improve their memory performance 
equal to that of wild-type mice (Greco et al, 2010). 
 Plasma leptin levels are determined by eating and adiposity in that leptin increases 
after eating and leptin levels increase with increased adiposity (Zhang et al, 1994; Maffei 
et al, 1995). As adiposity increases in the form of obesity, leptin resistance begins to 
develop where leptin levels are high but signaling is not functioning normally to decrease 
feeding and increase energy expenditure. Obesity and lack of exercise have been linked 
to the development of Alzheimer’s disease and low plasma leptin levels are also 
correlated to an increased chance of developing dementia (Beccano-Kelly and Harvey, 
2011; Lieb et al, 2009). Higher levels of plasma leptin were found to correlate with 
increased volume of the hippocampus and are protective against Alzheimer’s disease 
development (Lieb et al, 2009; Narita et al, 2009; Holden et al, 2009).  
 
2.7.1 LEPTIN & NEUROPROTECTION 
 In addition to being protective against the development of Alzheimer’s disease, 
other functions of leptin include more general neuroprotection and protection against 
apoptosis. Leptin can protect against oxidative stress under pathological conditions, for 
example with traumatic and ischemic brain injury (Zhang et al, 2008; Zhang et al, 2012). 
Leptin can also protect against excitotoxicity that can damage or kill neurons, as well as 
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protect against dementia, stroke and neuropathy (Dicou et al, 2001; Zhang et al, 2008; 
Guo et al, 2008; Lieb et al, 2009).  
 Leptin has antiapoptotic effects as well, cell cultures of a human neuroblastoma 
cell line were used to study these effects and it was found that leptin application increases 
cell number (Russo et al, 2004). The signaling pathways involved in the antiapoptotic 
effects of leptin were found to involve JAK/STAT, MAPK and PI3K with the ObRb 
(Russo et al, 2004). Leptin also has been shown to suppress apoptosis in non-neuronal 
cells, for example matured neutrophils and T cells, and the PI3K and MAPK pathways 
were found to be utilized (Bruno et al, 2005; Russo et al, 2004). These antiapoptotic 
effects are similar to the effects of leptin on progenitor cells that eventually differentiate 
into neurons, in that leptin can increase their number (Garza et al, 2008). Similarly, leptin 
can also increase overall hippocampal volume (Perez-Gonzalez et al, 2011). 
 
2.7.2. LEPTIN AS A TREATMENT 
 There is mounting evidence that shows leptin administration has positive and 
significant effects on cognition, learning and memory. Leptin can improve some of the 
memory deficiencies in Alzheimer’s disease as well as decrease tau phosphorylation 
(Freude et al, 2005; Valerio et al, 2006; Platt et al, 2016; Greco et al, 2008; Greco et al, 
2010). In normal mice, leptin has been shown to improve learning and memory in several 
behavioral tests (Rasi et al, 2006) and enhance LTP, dendritic spine density and 
neurogenesis (Wayner et al, 2004; Shanley et al, 2001; Garza et al, 2008; O’Malley et al, 
2007). Humans with congenital leptin deficiency have shown increases gray matter in 
some areas including the hippocampus after leptin replacement therapy (Paz-Filho et al, 
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2008; Matochik et al, 2005). Developmental delays in cognition, obesity, hypertension 
and dyslipidemia were all improved after two years of recombinant methionyl human 
leptin treatment in a five-year-old male patient with a leptin gene mutation (Paz-Filho et 
al, 2008). The current leptin therapy drug in use is metreleptin, brand name Myalept, for 
generalized lipodystrophy and congenital leptin deficiency (Paz-Filho, 2016). At this 
time, Maylept has only been FDA-approved for congenital or acquired generalized 
lipodystrophy (Paz-Filho, 2016).  
 As previously mentioned, administration of leptin through an injection directly 
into the hippocampus has been shown to have an antidepressant-like and anxiolytic- like 
effect in rats and mice as well as increase cognitive functions and in ob/ob mice, obesity 
and high corticosterone have been reduced after leptin injections were received (Collin et 
al, 2000; Lu et al, 2006; Harvey et al, 2005; Yamada et al, 2011; Guo et al, 2012; Sharma 
et al, 2010; Liu et al, 2010; Hwa et al, 1996; Mistry et al, 1997). Therefore, leptin 
presents as a very promising therapeutic agent for obesity, depression, anxiety, learning 
and memory. 
 Despite this evidence, leptin as a treatment presents a complicated problem. In 
obesity, leptin resistance develops such that administering leptin has no effect on weight 
loss (Chan et al, 2003). The benefits of leptin as a neuroprotective and synaptic plasticity-
enhancing agent have been shown, however leptin could have dire effects on cancer cells 
due to its antiapoptotic effects (Oomura et al, 2006; Farr et al, 2006; Tang, 2008). Leptin 
is also similar in structure to cytokines and would have the potential to increase 
inflammation if administered chronically (Heshka and Jones, 2001). For example, a study 
has monitored inflammation markers such as CRP, TNFalpha and cortisol and no 
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difference was found in these particular measures from saline controls (Greco et al, 
2010). However, there are many other pro-inflammatory cytokines that were not 
measured and leptin administration could impact levels of those cytokines which could 
lead to inflammation (Greco et al, 2010). There are also leptin receptors in the periphery 
and so leptin administration could result in side effects mediated through receptors there 
(Tartaglia et al, 1995; Lee et al, 1996; Fei et al, 1997; Ghilardi and Skoda, 1997; Hoggard 
et al 1997; Bjorbaek and Kahn, 2004).   
 The peptide nature of leptin also poses a problem for systemic injection since it is 
quickly and easily degraded. However, altering its transport in the blood can grant it a 
longer life and greater ability to interact with its receptors. A Pluronic block copolymer 
has been designed for this very purpose, Pluronic P85 (Price et al, 2010). The Pluronic 
P85 was combined with leptin and this resulted in the ability to pass through the BBB as 
well as a more than doubled half-life. To show the efficacy of the Pluronic P85 with 
leptin, evidence of a greater decrease in feeding in mice with the Pluronic leptin 
combination compared to vehicle was seen (Price et al, 2010). This indicates that the 
leptin did in fact reach the brain to decrease feeding behaviors. Although the effects of 
Pluronic leptin on learning and memory was not tested, it is feasible to suggest that 
Pluronic leptin would be able to enhance learning and memory in the hippocampus and 
have the other synaptic plasticity effects seen with direct leptin administration. 
Additionally, the actions of Pluronic leptin had a faster onset than leptin alone and 
continued to reach the brain and have effects at low and high doses, unlike leptin without 





CIRCUITRY: AN INTRODUCTION TO NEURONAL ACTIVATION 
 As mentioned above, leptin administration to the hippocampus has been shown to 
enhance LTP (Shanley et al, 2001; Wayner et al, 2004), increase morphology changes 
and neurogenesis (O’Malley et al, 2007; Garza et al, 2008), and facilitate spatial learning 
and memory (Harvey, 2007; Farr et al, 2006; Li et al, 2002; Oomura et al, 2006). Models 
of leptin deficiency and resistance have further supported the importance of leptin in 
synaptic plasticity by showing deficits in electrophysiological, morphological and 
behavioral tests that are improved after leptin restoration (Winocur et al, 2005; Li et al, 
2002; Grillo et al, 2011; Yamada et al, 2011). The effects of leptin when applied directly 
into the hippocampus have clear effects on synaptic plasticity; however, indirect 
pathways may be utilized by leptin that result in synaptic plasticity changes in the 
hippocampus. Due to the nature of the release of leptin from the peripheral adipocytes 
and the localization of leptin receptors throughout the brain, there is evidence that would 
support leptin mediating synaptic plasticity in the hippocampus through multi-synaptic 
circuitry.   
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3.1 NEURONAL ACTIVATION 
 In order to propose indirect circuits, the general effects of leptin on membrane 
potential and neurotransmitter systems in various brain regions must be analyzed. Leptin 
activates its leptin receptors on a neuron, resulting in signal cascades and release of 
neurotransmitter that can result in depolarization, hyperpolarization or no change in the 
membrane potential of the following neuron (Goforth et al, 2014; Spanswick et al, 1997; 
Cowley et al, 2001; van den Top et al, 2004; Lee et al, 2013; Powis et al, 1998; Dhillon et 
al, 2006). This results in a decrease, increase or no change in the following neuron’s 
likelihood to fire an action potential and release neurotransmitter. Depending on what 
type of neurotransmitters a neuron containing leptin receptors releases, leptin binding can 
result in the release of GABA or glutamate, inhibitory and excitatory neurotransmitters, 
respectively (Vong et al, 2011; Goforth et al, 2014; Tong et al, 2007). Other 
neurotransmitters may also be released and result in neuromodulatory effects or 
membrane potential differences; however, GABA and glutamate are the most ubiquitous 
neurotransmitters used in the brain. Excitatory postsynaptic potentials (EPSPs) occur 
when the presynaptic neuron undergoes an action potential, releases neurotransmitter, and 
the resulting change in membrane potential of the postsynaptic neuron becomes more 
positive, towards zero from -70 mV. EPSPs can summate temporally or spatially to result 
in an action potential in the postsynaptic neuron, beginning the process all over again in 
the downstream neuron. Conversely, an inhibitory postsynaptic potential (IPSP) results in 
the postsynaptic neuron’s membrane potential becoming more negative, hyperpolarized, 
and the neuron is less likely to fire. EPSPs and IPSPs summate continuously in neurons 
and result in a go or no-go firing response. Networks of neurons are able to be controlled 
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in such a way because neurons project axons to many dendrites of many different 
neurons, as many as 10,000 presynaptic neurons can project to a single neuron.  
 Calcium influx into the terminal is crucial for neurotransmitter release due to it 
being directly involved in neurotransmitter release from synaptic vesicles at the terminal 
of the axon boutons. Synaptic vesicles filled with neurotransmitter are located at the 
terminal ends of the axon boutons and vesicles undergo exocytosis after a series of events 
occurs. Calcium acts on synapsin, a protein involved in binding vesicles in the reserve 
pool and after a complex series of events, the vesicles are then free to dock to the plasma 
membrane and undergo exocytosis to release neurotransmitter into the synaptic cleft. 
Several proteins are involved with vesicle docking, including SNAP-25, increased by 
leptin application (Ahima et al, 1999). Once neurotransmitter is released into the synaptic 
cleft, it can act on the postsynaptic neuron and then be degraded or taken up by various 
enzymes or the presynaptic neuron or surrounding glia. 
 Leptin can bind to its receptors and activate signaling cascades in many areas of 
the brain, including the hippocampus, nuclei of the hypothalamus: VMH, DMH, lateral 
hypothalamus, ventral premammillary nucleus (PMv), arcuate, the ventral tegmental area 
(VTA), raphe nuclei, amygdala, and the brainstem (Elmquist et al, 1998; Morash et al, 
1999; Ur et al, 2002; Hay-Schmidt et al, 2001; Elias et al, 2000; Figlewicz et al, 2003; 
Fulton et al, 2006; Grill et al, 2002; Hommel et al, 2006; Leinninger et al, 2009; Leshan 
et al, 2009; Mercer et al, 1996; Munzberg, 2008; Scott et al, 2009). In order to determine 
whether leptin binds to and activates receptors in brain regions that express the ObRb, 
several techniques are used to determine whether neurons are activated by leptin. 
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Neuronal activation can be assessed using electrophysiology, immunoassay for Fos, 
assessing neurotransmitter release, and behavioral changes. 
 The c-Fos gene is transcribed quickly after a stimulus occurs, first observed after 
nicotinic acetylcholine receptors were activated and c-fos gene transcription and 
subsequent Fos expression occurred (Greenberg et al, 1986). c-Fos expression has also 
been shown to occur after seizures and other stimuli and therefore Fos expression, 
measured with an immunoassay, is now used to indicate activated neurons (Morgan et al, 
1987; Flavell and Greenberg, 2008). Peripheral leptin administration results in c-Fos 
expression in the hypothalamus, indicating activation of the neurons there (Woods et al, 
1996; Elmquist et al, 1997). 
 Neurotransmitter release, for example of glutamate, is another way to assess 
whether neurons have been activated. Once neurons are sufficiently depolarized and 
calcium has entered the axon terminals, vesicles containing neurotransmitter undergo 
exocytosis and release transmitter into the synaptic cleft. Microdialysis is a technique that 
utilizes the principles of dialysis, movement of molecules and water through a 
semipermeable membrane, to withdraw neurotransmitter into a microdialysis probe and 
then analyze and qualify with high performance liquid chromatography (HPLC) (Parent 
et al, 2001). The probe is filled with solution that contains the same concentrations as 
fluid in the brain so that small particles such as neurotransmitters can diffuse into the 
probe (Parent et al, 2001). Glutamate release can be measured with microdialysis and 
indicates neuronal activation because a neuron must be depolarized, or activated, to 
release its transmitter. Leptin acting on receptors in the VMH results in excitation of 
glutamatergic neurons there with subsequent glutamate release on the downstream 
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neurons (Canteras et al, 1994; Wang et al, 2015). This glutamate release can affect many 
other brain areas further downstream, as the VMH projects to many other regions such as 
POMC neurons in the arcuate, and the hippocampus (Canteras et al, 1994). A subdivision 
of POMC neurons in the arcuate nucleus that leptin activates have been shown to release 
acetylcholine in addition to the POMC and CART peptides (Meister et al, 2006). Another 
study has shown about a third of POMC neurons express the GABA synthesis enzyme, 
glutamic acid decarboxylase (Hentges et al, 2004). These data show how many 
neurotransmitter types and systems that may be influenced by leptin. 
 Behavioral changes are another way to assess when neurons have been activated 
by observing how behaviors change over time after some stimulus. As previously stated, 
leptin has been shown to affect learning, memory and cognition in several behavioral 
tests. Leptin injections improve performance in the Morris Water Maze, T-maze 
footshock and passive avoidance tests (Oomura et al, 2006; Rasi et al, 2006; Garza et al, 
2008; Farr et al, 2006). In leptin deficient or resistant animals, leptin restoration increases 
performance in several tests (Winocur et al, 2005; Li et al, 2002; Grillo et al, 2011; 
Yamada et al, 2011). Leptin also decreases depressive-like and anxiety- like behaviors in 
the forced swim test and also aids in stress management as seen in the chronic social 
defeat test (Lu et al, 2006; Liu et al, 2010; Sharma et al, 2010). These behavioral tests 
allow for changes at the neuronal level as a result of leptin to be seen on a macro scale. 
 
3.2 EXCITATION & INHIBITION BY LEPTIN 
 As previously stated, the ObRb is paired with the JAK/STAT signaling pathway 
to affect gene transcription, a process that can take days (Ghilardi et al, 1996). However, 
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the ObRb also utilizes PI3K and MAPK signaling and studies show that leptin can bind 
to receptors and immediately alter firing patterns using these pathways (Bjorbaek and 
Kahn, 2004; Glaum et al, 1996; Powis et al, 1998; Cowley et al, 2001; Schwartz and 
Moran, 2002). It is by rapid signaling with the PI3K and MAPK pathways that leptin 
binding is able to immediately alter membrane potential and hyperpolarize or depolarize 
neurons.  
 Leptin can have an activation effect or inhibition effect using the same receptor, 
the ObRb, and different signaling pathways such as PI3K or MAPK. In addition to these 
levels of specificity, leptin can also activate a calcium-activated potassium channel 
involved in inhibition in the hippocampus (Spanswick et al, 1997; Shanley et al, 2002). 
Additional studies have shown that PI3K signaling is involved in the calcium-activated 
potassium channel’s inhibition of hippocampal neurons, as the channel activation by 
leptin was blocked by PI3K antagonist wortmannin (Shanley et al, 2002). Calcium-
activated potassium channel activation is dependent on calcium concentration and it has 
been proposed that leptin activates these channels as a result of the ability of leptin to 
increase intracellular calcium concentration (Oomura et al, 2006). Shanley and colleagues 
have proposed that NMDA receptor current is enhanced by leptin; however at rest, leptin 
inhibits hippocampal neurons through the calcium-activated potassium channels (Shanley 
et al, 2002).   
 Which brain areas and neuronal populations are excited or inhibited by leptin and 
which neurotransmitters are released in response to leptin binding is a current area of 
research. Studying activation and inhibition using Cre/lox technology has allowed much 
greater understanding of which neuronal populations that respond to leptin in the 
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hypothalamus are activated or inhibited by leptin binding and what neurotransmitter 
systems are involved. Vong and colleagues generated Vgat-ires-Cre and Vglut2-ires-Cre 
mice to express Cre recombinase in GABAergic or glutamatergic neurons, respectively 
(Vong et al, 2011). Crossing these mice with lox-green fluorescent protein (GFP) reporter 
mice allows for detection of GFP using immunohistochemistry and so the ability to 
determine which neurons are GABAergic or glutamatergic. 
 Studying colocalization of leptin receptor activity, using pSTAT3, and GFP 
expression in Vgat-ires-Cre mice showed which areas of the hypothalamus that contained 
GABAergic neurons with leptin receptors. Colocalization was found in the arcuate, DMH 
and lateral hypothalamus. Similar experiments were completed in Vglut2-ires-Cre mice 
and it was determined that the following areas had glutamatergic neurons with leptin 
receptors: a small part of the arcuate, VMH and PMv (Vong et al, 2011). These data 
show that leptin not only activates GABAergic neurons but also glutamatergic neurons in 
the hypothalamus that can project and release their respective neurotransmitters to many 
other brain regions, including the hippocampus (Canteras et al, 1994).  
 Vgat-ires-Cre and Vglut2-ires-Cre mice were also crossed with Lepr flox/flox 
mice to target leptin receptors from only GABAergic or glutamatergic neurons. This 
resulted in the mice that lacked leptin receptors on GABAergic neurons gaining a 
significant amount of weight. This led to an understanding that leptin predominantly 
utilizes GABAergic neurons for its regulation of body weight and energy expenditure 
(Vong et al, 2011). While it was determined in this set of experiments that leptin uses 
GABAergic inhibition for its food intake and energy balance effects, the effect of leptin 
on the glutamatergic population in the hypothalamus was not studied (Vong et al, 2011). 
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Another study knocked down glutamatergic neurons containing leptin receptors in the 
hypothalamus and saw that mice had lower body temperatures and energy expenditures 
compared to controls, as measured by oxygen consumption (Xu et al, 2013). It was 
determined that these glutamatergic neurons are important in thermoregulation and 
energy expenditure, however, no measures of synaptic plasticity were analyzed in the 
hippocampus. It is possible then that leptin binding to leptin receptors on glutamatergic 
neurons in the hypothalamus project to the hippocampus and utilize glutamate to affect 
synaptic plasticity. 
 To propose where a circuit influenced by leptin can begin, brain regions that 
express leptin receptors must be determined and then what effect leptin has once it 
activates those receptors, then subsequent projections and neurotransmitters. Leptin 
receptors have been found in the following hypothalamic regions: VMH, DMH, LH, and 
PMv. In addition, leptin receptors have been found in the hippocampus, VTA, the raphe 
nuclei, brainstem, parabrachial nucleus, periaqueductal gray, dorsal vagal complex 
(Hakansson et al, 1998; Elmquist et al, 1998; Burguera et al, 2000; Haung et al, 1996; 
Mercer et al, 1996; Leinninger et al, 2009; Scott et al, 2009; Grill et al, 2002; Elias et al, 
2000; Figlewicz et al, 2003; Fulton et al, 2006; Hommel et al, 2006; Leshan et al, 2009; 
Munzberg, 2008;). These areas pose potential starting points for circuitry involving the 
hippocampus and synaptic plasticity there.  
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3.3 LEPTIN & OREXIN: APPETITIVE PEPTIDES WITH INDIRECT CIRCUITRY 
 The indirect routes that leptin may use to facilitate synaptic plasticity in the 
hippocampus are mirrored by the peptides orexin A and orexin B. Orexin A and orexin B 
are appetitive peptides that arise from the same Ox gene, cleaved to yield two peptides 
(Akbari et al, 2007). The orexin-1 receptor has a greater binding affinity for orexin A and 
the orexin-2 receptor has approximately the same affinity for both orexins (Sakurai et al, 
1998). The orexins are produced by neurons located exclusively in the lateral 
hypothalamus and perifornical areas that stimulate feeding, wakefulness and are involved 
in sleep (Nambu et al, 1999; Peyron et al, 1998; Sakurai et al, 1998; de Lecea et al, 1998; 
O’Leary, 2014). Orexin is similar to leptin in that it may also utilize whole-brain 
circuitry, strengthening the argument that appetite and energy balance-related peptides 
are able to manipulate synaptic plasticity using brain-wide networks.  
 Orexin receptors are widespread throughout the brain, including the hippocampus, 
septum, arcuate nucleus, lateral hypothalamus, paraventricular nucleus of the 
hypothalamus, dorsal raphe nucleus and locus coeruleus (Cluderay et al, 2002; Wayner et 
al, 2004; Backberg et al, 2002; Akbari et al, 2006; Marcus et al, 2001). Orexigenic 
neurons from the lateral hypothalamus have been found to project to many areas of the 
hypothalamus, locus coeruleus, dorsal raphe, as well as the hippocampus (Date et al, 
1999; Peyron et al, 1998). Interestingly, orexin A has been shown to be involved in 
hippocampal LTP, learning and memory, mirroring the roles of leptin in the 
hippocampus. For example, orexin A has also been shown to improve memory 
processing in the T-maze footshock avoidance and enhance LTP in the perforant pathway 
of the dentate gyrus (Akbari et al, 2006; Wayner et al, 2004; Jaeger et al, 2002). Orexin 
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administration to the dentate gyrus enhanced LTP and leptin also enhanced LTP dose-
dependently, inhibiting LTP at the smallest and largest doses (Wayner et al, 2004). These 
data are consistent with another study showing that leptin facilitates and enhances LTP 
dose-dependently with an inverse U dose response curve (Wayner et al, 2004; Oomura et 
al, 2006). The orexin-1 receptor selective antagonist SB-334867 administered in the CA1 
region of the hippocampus with MWM resulted in decreased time spent in the area where 
the platform had been and showed impaired acquisition (Akbari et al, 2006). These 
results show that the output of signaling with the orexin-1 receptor in the hippocampus is 
remarkably similar to that of leptin in terms of behavioral, learning and memory. This 
evidence that orexin affects synaptic plasticity in the hippocampus similarly to the way 
that leptin does is further evidence that orexin and leptin both work by direct and indirect 
circuitry. 
 Leptin and orexin appear to act in opposition in several brain areas, including the 
hypothalamus. Leptin has opposite effects on two different neuronal populations in the 
arcuate nucleus that project to the lateral hypothalamus, seen by Fos expression and tract-
tracing (Elias et al, 1999). Leptin inhibits via hyperpolarizing AgRP/NPY neurons in the 
lateral hypothalamic area and medial arcuate nucleus while exciting neurons via 
depolarizing POMC/CART neurons in the medial and lateral arcuate (Elias et al, 1999; 
Cowley et al, 2001; Takahashi and Cone, 2005; van den Top et al, 2004). Orexin has an 
opposite effect, it can depolarize both AgRP/NPY and POMC/CART neurons (van den 
Top et al, 2004; Guan et al, 2001). The role of orexin in feeding behaviors act in 
opposition to leptin, to stimulate food intake and decrease energy expenditure (de Lecea 
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et al, 1998; Sakurai et al, 1998; Edwards et al, 1999). It would appear then that leptin and 
orexin have related, but opposite effects in the lateral hypothalamus.  
 One study looked at the effect of leptin and orexin administration in tissue slices 
of the arcuate nucleus in the hypothalamus and extracellular recordings showed that some 
of the same cells that were activated by orexin were also inhibited by leptin (Rauch et al, 
2000). Orexin A excited around 85% of the neurons in the arcuate nucleus whereas leptin 
only elicited any change in about 24% of the neurons in the arcuate nucleus (Rauch et al, 
2000). This is interesting to connect to another study’s findings that the leptin receptors 
in the arcuate nucleus are primarily GABAergic with a small amount being glutamatergic 
(Vong et al, 2011). Interestingly, about half of the neurons were inhibited and half were 
excited and the longer leptin was present in the arcuate nucleus, the greater the inhibition 
(Rauch et al, 2000). These results show that leptin inhibited and excited a small amount 
of neurons in the arcuate and orexin only excited a much larger percentage, showing 
again an opposition in the same area and electrophysiological effects.  
 Interestingly, leptin has been shown to inhibit orexin neurons in the lateral 
hypothalamus, as seen in bath application of leptin in hypothalamic slices (Yamanaka et 
al, 2003). Leptin application causes hyperpolarization of orexin neurons and decreases 
the firing rate in a dose-dependent manner, higher levels of inhibition with higher doses 
of leptin (Yamanaka et al, 2003). It was also found that administering leptin to ob/ob 
mice increased orexin mRNA expression, while leptin given to wild-type mice resulted in 
suppression of orexin mRNA (Yamanaka et al, 2003). The difference is proposed as 
being related to the elevated glucose levels in ob/ob mice, that orexin neurons are 
inhibited in hyperglycemia, as pair-feeding ob/ob mice to wild-type mice, lowering food 
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intake, lowered blood glucose to normal levels and increased orexin mRNA levels 
(Yamanaka et al, 2003). The mechanism behind the ability of leptin to inhibit orexin 
neurons has been elucidated. Lateral hypothalamic neurons that express both leptin 
receptors and neurotensin are activated and subsequently hyperpolarize orexin neurons. 
This is further supported by an experiment showing that the removal of the leptin 
receptor from these neurons removes the hyperpolarizing effect on orexin neurons 
(Goforth et al, 2014). Interestingly, blocking GABA transmission did not remove the 
hyperpolarization effect of leptin and so it was determined that leptin application 
decreases EPSCs onto orexin neurons by lowering the amount of glutamate released onto 
orexin neurons and opening an ATP-sensitive potassium channel on orexin neurons 
(Goforth et al, 2014). These data show that leptin inhibits orexin neurons not with GABA 
or by leptin receptors located on orexin neurons but indirectly, through a potassium 
channel and by decreasing the frequency of EPSCs onto orexin neurons (Leinninger et al, 
2009; Louis et al, 2010; Laque et al, 2013; Goforth et al, 2014). 
 Electrical stimulation of the lateral hypothalamus, locus coeruleus and other areas 
that contain both orexin and leptin receptors have been shown to affect synaptic plasticity 
in the hippocampus (Akbari et al, 2006; Frey et al, 2001; Walling et al, 2004; Wayner et 
al, 1997). The locus coeruleus produces norepinephrine, and norepinephrine in the 
dentate gyrus stimulates LTP. In this regard, orexin was directly injected into the locus 
coeruleus which resulted in norepinephrine release into the dentate gyrus which in turn 
enhanced EPSPs in the dentate gyrus (Walling et al, 2004). Similar results were seen 
when stimulating the basolateral amygdala in that transient LTP was seen 30 minutes 
after stimulating the basolateral amygdala with high frequency pulses (Frey et al, 2001). 
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Whole stimulation of the lateral hypothalamus results in blocking LTP in the dentate 
gyrus (Wayner et al, 1997). Leptin has been shown to act directly on its receptors in the 
lateral hypothalamus and these leptin-expressive neurons that colocalize with leptin 
receptors are GABAergic (Vong et al, 2011). This could be interpreted in a variety of 
ways, including that leptin inhibits inhibition of LTP in the dentate gyrus by activating 
GABAergic neurons in the lateral hypothalamus.  
 These stimulation studies are evidence that indirect pathways could be utilized by 
orexin and leptin and these pathways have already demonstrated that synaptic plasticity is 
affected through electrical stimulation.  While the above studies are limited to only 
studying a few brain regions, it can be expected that synaptic plasticity would be affected 
if other brain regions were stimulated. This provides a strong argument that indirect 
pathways of leptin to influence synaptic plasticity are very likely used. 
 The mechanisms through which leptin and orexin act in opposition in many brain 
regions such as the arcuate nucleus of the hypothalamus while also having very similar 
actions on synaptic plasticity in the hippocampus could be an example of two different 
multi-synaptic sets of circuitry (Rauch et al, 2000; Akbari et al, 2006; Wayner et al, 2004; 
Jaeger et al, 2002). Evidence that stimulation of brain regions that contain both orexin 
and leptin receptors influences synaptic plasticity in the hippocampus provides further 
support that these appetitive peptides operate using several networks, starting in one brain 





INDIRECT PATHWAYS FOR LEPTIN TO AFFECT SYNAPTIC 
PLASTICITY
4.1 LEPTIN RECEPTORS IN THE VENTRAL TEGMENTAL AREA 
 Leptin receptors and leptin receptor mRNA have been found in the ventral 
tegmental area (VTA), an area composed of dopaminergic neurons involved reward, 
emotion, and other behaviors (Leshan et al, 2010; Figlewicz et al, 2003; Fulton et al, 
2000; Fulton et al, 2006; Leinninger et al, 2009; Hommel et al, 2006; Ranaldi, 2014). The 
VTA, substantia nigra and the projections from both are part of the mesolimbic dopamine 
system. These dopaminergic neurons project to many regions including the striatum, 
amygdala, nucleus accumbens and hippocampus to the subiculum and areas CA1 and 
CA3 (Bjorklund and Dunnett, 2007a; Leshan et al, 2010; Lammel et al, 2008; Gasbarri et 
al, 1991).  
Leptin has been shown to directly activate dopaminergic neurons (Hommel et al, 
2006; Fulton et al, 2006; Leinninger et al, 2009). The activation of leptin receptors 
directly on VTA neurons was assessed by looking at whether STAT3 was phosphorylated 
after leptin administration (Ghilardi et al, 1996; Hommel et al, 2006). Leptin was injected 
directly into the VTA and significant pSTAT3 was seen on tyrosine hydroxylase-
containing neurons, neurons that contain the enzyme to synthesize dopamine (Hommel et 
al, 2006). Interestingly, direct injection of leptin into the VTA resulted in less food 
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intake, a behavioral effect similar to that of leptin injections into the arcuate nucleus of 
the hypothalamus (Elmquist et al, 1998; Huang et al, 1996).  
The electrophysiological effects of leptin on dopaminergic VTA neurons was 
assessed both in vivo and in vitro with single-cell recordings and in brain slices, 
respectively. In vivo, leptin decreased the frequency of dopaminergic neuron firing and in 
vitro, bath application of leptin resulted in a hyperpolarization of the membrane (Hommel 
et al, 2006). These data show that leptin directly acts in the VTA to influence behavior as 
well as firing rate of the neurons there. These experiments did not include an assessment 
of any synaptic plasticity effects as a result of direct application of leptin in the VTA but 
due to the measured effects on feeding behavior and firing rate and the projections from 
the VTA to the hippocampus, it is possible synaptic plasticity in the hippocampus could 
be altered by this pathway. 
 Dopaminergic neurons project to the subiculum, to the cells of the dentate gyrus 
and pyramidal neurons in areas CA1 and CA3 and these dopaminergic projections have 
been shown to affect synaptic plasticity in the form of LTP (Hortnagl et al, 1991; Verney 
et al, 1985; Gasbarri et al, 1991; Jay, 2003). Antagonism of dopamine receptors in area 
CA1 results in failure to maintain LTP and agonists of dopamine receptors in area CA1 
increase the slope of EPSPs (Huang and Kandel, 1995; Frey et al, 1990). LTP in response 
to dopamine has been assessed in the dentate gyrus but to mixed results; one found no 
effect, another found LTP to not be induced with agonist but lengthened the time LTP 
was present, some found LTP was induced with agonist (Swanson-Park et al, 1999; 
Yanagihashi and Ishikawa, 1992; Kusuki et al, 1997). It appears, then, that dopamine 
acting on dopamine receptors in area CA1 increases the slope EPSPs and blocking 
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dopamine receptors negatively effects LTP maintenance whereas in the dentate gyrus, 
LTP was induced or lengthened depending on the study. The effects of leptin on 
membrane potential and firing rate in the VTA which projects directly to the 
hippocampus in combination with the effects of dopamine on hippocampal LTP provides 
a potential indirect route through which leptin may affect hippocampal synaptic plasticity 
(Leinninger et al, 2009; Hortnagl et al, 1991; Verney et al, 1985; Gasbarri et al, 1991; 
Miler and Bacon, 1989).   
 It should be noted that this information conflicts with the observation that ob/ob 
mice have lower levels of tyrosine hydroxylase mRNA compared to wild-type, the lack 
of leptin in circulation would seem to result in more tyrosine hydroxylase and potentially 
more dopamine release due to the lack of inhibition in the VTA reported in the study 
(Hommel et al, 2006; Fulton et al, 2006; Leinninger et al, 2009). The electrophysiological 
studies also conflict with another study that shows that systemic injections as well as 
hypothalamic injections of leptin result in increased amphetamine- induced dopamine 
release in the nucleus accumbens (Perry et al, 2010). These studies differ on the manner 
of leptin application, indirect vs direct in the VTA resulting in more and less release of 
dopamine, respectively. These conflicting results support leptin using different circuitry 
to exert different effects, depending on the location of leptin binding. 
 To further support that leptin could increase dopamine levels in the mesolimbic 
system by some pathways, activation of leptin-receptor containing neurons that project 
from the lateral hypothalamus to the VTA have been shown to increase the enzyme 
involved in dopamine production in the VTA (Leinninger et al, 2009; Leshan et al, 2010; 
Hommel et al, 2006). Direct injection of leptin into the lateral hypothalamus resulted in 
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increased pSTAT3 in the lateral hypothalamus and increased tyrosine hydroxylase levels 
in the VTA in both ob/ob and wild-type mice (Leinninger et al, 2009). Leptin injected 
peripherally resulted in dopamine release into the nucleus accumbens and enhanced 
dopamine transporter and tyrosine hydroxylase activity in the nucleus accumbens (Perry 
et al, 2010). This shows that leptin receptor-containing neurons from the lateral 
hypothalamus not only are being activated by leptin but project to the VTA to increase 
the levels of dopamine-synthesizing enzyme to potentially alter dopamine levels in the 
mesolimbic system. The differences in direct electrophysiological effects of leptin in the 
VTA and systemic or hypothalamic  injection of leptin on dopamine release has sparked 
controversy in the field and perhaps networks of inhibitory and excitatory effects of 
leptin in the VTA or projecting to the VTA play a role in altering synaptic plasticity in 
the hippocampus.  
 Leptin receptor-containing neurons from the VTA also project to the central 
amygdala (Leshan et al, 2010). The amygdala, specifically the basal nuclei, indirectly 
project to the hippocampus through the prelimbic prefrontal cortex (McDonald et al, 
1996; Vertes, 2004). Leptin administered to ob/ob mice resulted in an increase in 
phosphorylated CREB, an indicator of activity, showing that leptin increased activity in 
the neurons in the central amygdala (Leshan et al, 2010). The lateral hypothalamus also 
projects to the amygdala, providing an additional indirect route to the hippocampus 
(Hahn and Swanson, 2015; Goto et al, 2005). This could result in several pathways 
activated by leptin, beginning in the central amygdala to the basal nuclei and ultimately 
to the hippocampus.   
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4.2 LEPTIN RECEPTORS IN THE LOCUS COERULEUS  
 The locus coeruleus is the main center in the brain for production of 
norepinephrine, classically involved in attention and memory and there is significant 
norepinephrine input to the hippocampus, specifically to the adrenergic receptors in the 
dentate gyrus (Loughlin et al, 1986; Booze et al, 1993). The locus coeruleus also 
expresses leptin receptors, as seen by immunohistorychemistry studies double-labeling 
leptin receptors and tyrosine hydroxylase and the dorsal locus coeruleus projects to the 
hippocampus (Hay-Schmidt et al, 2001; Elmquist et al, 1998; Loughlin et al, 1986). The 
direct effects of leptin in the locus coeruleus have not been explored; however there are 
projections from leptin-receptor containing neurons from the lateral hypothalamus to the 
locus coeruleus (Laque et al, 2015). This could be a route by which leptin could regulate 
the locus coeruleus that in turn goes on to project to the hippocampus (Loughlin et al, 
1986).  
 Norepinephrine has been implicated in LTP in the perforant pathway of the 
dentate gyrus (Walling et al, 2003). Norepinephrine-induced LTP can be blocked by the 
same NMDA receptor antagonist that blocks LTP in the dentate gyrus, D-(-)-2-amino-5-
phosphonovaleric acid, demonstrating norepinephrine’s importance to LTP in the dentate 
gyrus (Dahl et al, 1989). Depleting norepinephrine with 6-OHDA resulted in a decrease 
of frequency of LTP in the dentate gyrus only, no change in frequency seen in LTP in 
area CA1 (Stanton and Sarvey, 1985). Other studies have found that stimulating the locus 
coeruleus results in inhibition or excitation of the dentate gyrus and others have found 
norepinephrine activating its receptors in the dentate gyrus to induce LTD (Segal and 
Bloom, 1976; Dahl and Winson, 1985; Hansen and Manahan-Vaughan, 2015).  
 
68 
 One group looked at the effects of leptin on catecholamine release when leptin is 
injected i.c.v. into the VMH, arcuate, paraventricular and dorsomedial hypothalamic 
nuclei (Satoh et al, 1999). It was found that leptin injected into the VMH resulted in 
increases in plasma norepinephrine and epinephrine proportional to the dose of leptin 
injected. The other areas of the hypothalamus did not see such increases (Satoh et al, 
1999). This provides evidence that leptin has influence over norepinephrine release 
mediated through the VMH of the hypothalamus that could bind to adrenergic receptors 
in the hippocampus and induce LTP or LTD (Loughlin et al, 1986; Booze et al, 1993).  
 Lesions of the locus coeruleus have resulted in less preference for sucrose and 
less food intake that reversed 5 days later, showing that the locus coeruleus is similarly 
involved in the modulation of feeding behaviors and therefore could also be involved in 
leptin regulating synaptic plasticity (Ammar et al, 2001). Treatment with an alpha 2 
receptor agonist, clonidine, resulted in less food intake in both ob/ob and wild-type mice; 
however, another study used an alpha 2 receptor antagonist that reduced food intake 
while clonidine increased carbohydrate and total food intake (Currie and Wilson, 1991; 
Currie and Wilson, 1992). Although these results are inconsistent with each other, they 
show that leptin may have some control over the locus coeruleus in feeding behaviors and 
therefore also control over locus coeruleus’ projections to the hippocampus. 
 
4.3 LEPTIN RECEPTORS IN THE RAPHE NUCLEUS 
 The raphe nucleus is the primary site of synthesis for serotonin, a neurotransmitter 
involved in feeding, sleep and depressive disorders (Lam and Heisler, 2007; Lucki, 1998; 
Pinder and Wieringa et al, 1993; Jouvet et al, 1967). A high level of immunoreactivity of 
 
69 
the leptin receptor has been located in the raphe and double label in situ hybridization has 
shown that leptin receptor-containing neurons that express the serotonin transporter 
mRNA are present in the caudal linear, dorsal and medial raphe although there is some 
controversy over this (Hay-Schmidt et al, 2001; Finn et al, 2001; Lam et al, 2011). The 
dorsal and medial areas of the raphe, have been shown to project directly to the 
hippocampus, hypothalamus and amygdala, providing an indirect route to the 
hippocampus through which leptin can act (Vertes et al, 1999; Azmitia and Segal, 1978; 
Sawchenko et al, 1983; Willoughby and Blessing, 1987; Donovan and Tecott, 2013; 
Petrov et al, 1992).  
 In support of this hypothesis, digoxigenin- labelled leptin was injected into the 
lateral cerebral ventricle and confocal microscopy was used to identify that labelled leptin 
had accumulated in serotonergic neurons of the dorsal raphe (Fernandez-Galaz et al, 
2002). To further support that leptin acts in the raphe nucleus, an injection of leptin into 
the brainstem has been shown to activate leptin receptors on serotonergic neurons in the 
dorsal and medial raphe nucleus of wild-type mice, confirmed by immunohistochemistry 
for pSTAT3 (Yadav et al, 2009). Leptin injected i.c.v. was found to significantly 
correlate with higher levels of brain serotonin after three hours (Calapai et al, 1999). It 
was also found that, with in situ hybridization, ob/ob mice have less serotonin transporter 
mRNA compared to controls, implying a relationship between leptin and serotonin 
(Collin et al, 2000). Additionally, deletion of leptin receptors on serotonergic neurons in 
the brainstem resulted in decreased energy expenditure and the development of obesity, 
further supporting this relationship (Yadav et al, 2009). These data demonstrate that 
leptin activates serotonergic neurons in the raphe and that in ob/ob mice, serotonin 
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transporter mRNA expression is decreased, indicating an interaction between leptin and 
serotonergic neurons.  
 Leptin has been shown to have electrophysiological effects in wild-type mice, 
however this data also comes with some controversy. Leptin bath application has been 
shown to decrease the frequency of action potentials of serotonergic neurons in brain 
slices with the application of phenylephrine, an alpha-1 adrenergic receptor agonist 
(Yadav et al, 2009). Another study reported no change with bath application of leptin on 
brain slices of wild-type mice, however phenylephrine was not added to the bath (Lam et 
al, 2011; Yadav et al, 2009). The former paper has added that serotonergic neurons have 
lost norepinephrine input in slices and therefore are dormant without the adrenergic 
receptor agonist, a more physiologically relevant observation (Yadav et al, 2009). These 
electrophysiological data show that leptin directly effects serotonergic neurons that go on 
to project to the hippocampus (Yadav et al, 2009; Vertes et al, 1999; Azmitia and Segal, 
1978; Sawchenko et al, 1983; Willoughby and Blessing, 1987; Donovan and Tecott, 
2013; Petrov et al, 1992). 
 Serotonin acting on the different serotonin receptor sub-types have been found to 
alter both glutamate and GABA release in different brain regions. In the cortex and 
septum, serotonin binding to the 5-HT2 receptor increases glutamate release while in the 
cerebellum, decreases glutamate release (Aghajanian and Marek, 1997; Hasuo et al, 
2002; Torres-Escalante et al, 2004; Maura et al, 1991). In contrast, serotonin binding to 
the 5-HT3 receptor increases GABA in area CA1 while antagonism of the 5-HT7 
receptor in area CA3 alters GABA-mediated activity (Gill et al, 2002; Katsurabayashi et 
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al, 2003). It would seem that serotonergic effects depend on both brain region and 
serotonin receptor subtype.  
 Serotonergic neurons innervate the dentate gyrus and have been shown to increase 
neurogenesis there (Malberg et al, 2000). Additionally, inhibiting serotonin synthesis 
decreased the rate of neurogenesis in the dentate gyrus, showing the importance of 
serotonin in neurogenesis (Brezun and Daszuta, 1999; Djavadian, 2004). Interestingly, 
depletion of serotonin using 5,7-DHT or PCPA in hippocampal slices did not affect 
frequency of LTP in either the dentate gyrus or area CA1 and only amplitude was non-
significantly decreased with PCPA (Stanton and Sarvey, 1985). In hippocampal slices, 
the application of exogenous serotonin or serotonin receptor agonists have resulted in 
inhibition (Mlinar et al, 2003; Jahnsen, 1980, Pugliese et al, 1998). In contrast, 
application of 3,4-methylenedioxymethamphetamine (MDMA) to trigger endogenous 
release of serotonin resulted in facilitation of greater LTP in areas CA3 and CA1 (Rozas 
et al, 2011). The difference between these two results seems to depend on exogenous vs 
endogenous serotonin and that using MDMA to result in the release of serotonin from 
axons in areas CA3 and CA1 results in greater LTP (Mlinar et al, 2015). Endogenous 
serotonin, then, appears to enhance both LTP and neurogenesis and so the raphe nucleus 
is a candidate for a potential indirect pathway for leptin to influence synaptic plasticity in 
the hippocampus.  
 
4.4 LEPTIN RECEPTORS IN THE LATERAL HYPOTHALAMUS 
 The hippocampus is increasingly considered as being involved in feeding 
behaviors and energy regulation, in addition to its roles in learning and memory 
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(Davidson et al, 2005, Davidson et al, 2007). Reciprocal connections from area CA1 of 
the hippocampus to various nuclei in the hypothalamus have been identified. Area CA1 
projects directly to the VMH, lateral hypothalamus and the midline thalamic nuclei 
(Cenquizca and Swanson, 2007). It has been suggested that these projections may be 
involved in motivated behaviors, such as feeding (Cenquizca and Swanson, 2007). 
Additionally, the VMH, lateral hypothalamus and midline thalamic nuclei send 
projections to the hippocampus (Lima et al, 2013; Canteras et al, 1994). To further 
support the connection of the hippocampus to the hypothalamus, it has been shown that 
lesioning projections from the hippocampus to the PVN resulted in a significant increase 
in CRH mRNA expression in the PVN (Herman et al, 1992). This demonstrates a direct 
influence of the hippocampus on an area of the hypothalamus that has further 
downstream effects on the hypothalamic-pituitary-adrenal axis (HPA) and release of 
cortisol from the adrenals. The lateral hypothalamus has both GABAergic and 
glutamatergic neuronal populations and have been shown to be involved in feeding 
(Jennings et al, 2013; Wu et al, 2015). These data show that the hippocampus is directly 
connected to the hypothalamus and due to leptin receptors being located in both the 
hypothalamus and hippocampus, there could be bidirectional effects of leptin in these 
brain regions (Morash et al, 1999; Ur et al, 2002).  
 Studies have recently elucidated a pathway from the ventral hippocampus to the 
dorsal perifornical lateral hypothalamus activated by ghrelin, an appetitive hormone from 
the stomach (Tschop et al, 2000; Cowley et al, 2003; Hsu et al, 2015). Ghrelin is 
proposed as being involved in meal anticipation, as deletion of its receptor blocks 
anticipation of food (Blum et al, 2009). The ventral hippocampus has leptin and ghrelin 
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receptors and the ventral hippocampus projects directly to the lateral hypothalamus, 
discovered using tract tracing and immunohistochemistry approaches (Hsu et al, 2015). 
Additionally, in the same set of experiments, it was found that blocking ghrelin receptors 
in the ventral hippocampus resulted in decreased food intake when rats were only 
allowed to feed for one 4 hour-window each day after meal entrainment. These data show 
how an appetite and energy-related hormone utilizes a direct route from the hippocampus 
to the lateral hypothalamus for meal anticipation and food intake, evidence that leptin 
could be using the same pathway to effect synaptic plasticity changes in the 
hippocampus.  
 Leptin is similarly involved in feeding behaviors and so could be acting through 
this pathway as well. Several groups have explored the role of leptin in the ventral 
hippocampus. Leptin also has a role in a type of learning and memory, food-related 
spatial learning and memory that is mediated by the ventral hippocampus specifically (de 
Hoz et al, 2003; Bannerman et al, 2004; Kanoski et al, 2011). The dorsal hippocampus is 
correlated with spatial memory and the ventral hippocampus is correlated with emotional 
and motivational memory (de Hoz et al, 2003; Bannerman et al, 2004; Fanselow and 
Dong 2010; Kanoski et al, 2011). Leptin injected directly into the ventral hippocampus 
resulted in decreased food intake, similar to leptin injections into the hypothalamus 
(Kanoski et al, 2011). This would indicate a link between the leptin, ventral hippocampus 
and hypothalamus.  
 Conditioned Place Preference (CPP) is a hippocampal-dependent test designed to 
link a rewarding event, such as food, with the location in the environment where the 
rewarding event took place (Ito et al, 2006). When leptin was again injected directly into 
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the ventral hippocampus 3 hours prior to the CPP test, the food-related conditioned place 
preference was inhibited, compared to vehicle controls. Leptin administered directly into 
the dorsal hippocampus did not see such an inhibition. So then, memory consolidation for 
the location of the food was only impaired when leptin was injected into the ventral 
hippocampus and not the dorsal hippocampus. The activation of the leptin receptors in 
the ventral hippocampus in this experiment are thought to block the recall of memories 
related to food by cues in the environment (Kanoski et al, 2011).  
 Leptin in the ventral hippocampus not only has an impact on food-related 
behaviors but also memory recall. And while synaptic plasticity measures such as LTP or 
non-food related behavioral studies were not conducted in this experiment, it is likely 
synaptic plasticity changes compared to controls would have been seen. The authors 
suggest that the hypothalamus is not the only brain region involved in regulation by leptin 
of food intake and energy balance which can translate to regulation of synaptic plasticity 
by leptin, dispersed throughout the brain and connected through many synapses. Leptin 
very likely utilizes a network, not just one brain region, for its effects on both food intake 
and metabolism but also synaptic plasticity and this idea has been suggested by several 
other studies in relation to the effects of leptin on energy expenditure and food intake 
(Leinninger and Myers, 2008; Myers et al, 2009).   
 
4.5 LEPTIN RECEPTORS IN THE PARAVENTRICULAR HYPOTHALAMUS 
 The paraventricular nucleus of the hypothalamus (PVN) is involved in controlling 
pituitary, feeding and autonomic functions (van den Pol and Trombley, 1993; Buijs et al, 
2003; Coote, 1995; Ferguson et al, 2008). There are many populations of neurons within 
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the PVN, including neurons that contain corticotropin-releasing factor (CRF), thyrotropin 
releasing hormone (TRH) and oxytocin (Perello and Raingo, 2013; Legradi et al, 1997; 
Herman et al, 1989). Neurons that contain glutamate or GABA have also been identified 
in the PVN, glutamatergic and GABAergic neurons were identified with 
immunocytochemistry for rapid excitatory and inhibitory transmission, respectively, in 
the PVN (van den Pol and Trombley, 1993; Decavel and van den Pol, 1990). 
 Leptin application results in changes in membrane potential in hypothalamic brain 
slices that included the PVN (Powis et al, 1998). Whole-cell recordings were completed 
and bath application of leptin resulted in depolarized the majority of neurons and this 
effect was dose-dependent (Powis et al, 1998). To further investigate the effect of leptin 
on current, it was found that bath application of leptin increased the amplitude of inward 
current (Powis et al, 1998). These results are supported by a study that found Fos 
expression in the PVN after leptin was administered peripherally (Elmquist et al, 1997). 
These data show that leptin directly activates neurons in the PVN, mediated through 
leptin receptors there (Elmquist et al, 1998; Elmquist et al, 1997). A study has found 
projections from the PVN to area CA2 of the hippocampus, using retrograde tracers (Cui 
et al, 2013). In addition, the PVN projects to many areas that in turn project to the 
hippocampus, including: the DMH, VMH, lateral septum, bed nucleus of the stria 
terminalis, amygdala, pituitary gland, spinal cord and several others (Moga et al, 1995; 
Swanson and Kuypers, 1980). The electrophysiological data in combination with direct 
and indirect projections of the PVN to the hippocampus result in several potential 




 Leptin receptors are found in the PVN on a variety of different neurotransmitter-
containing neurons, including neurons that contain TRH (Legradi et al, 1997). Release of 
TRH from the PVN regulates the release of thyroid stimulating hormone (TSH) from the 
pituitary gland which then stimulates the thyroid to synthesize and release T3 and T4, the 
thyroid hormones (Flier et al, 2000). TRH release is reduced during fasting, when leptin 
levels are low. Leptin activates TRH-containing neurons and can therefore regulate the 
hypothalamic-pituitary-thyroid axis (HPT) axis. Thyroid hormone levels increase with 
leptin treatment after fasting rats and leptin application results in TRH release in 
hypothalamic cell cultures (Ahima et al, 1996; Legradi et al, 1997; Blake et al, 1991; Kim 
et al, 2000; Nillni et al, 1999). Another study has shown that leptin administration 
brought T4 and T3 levels back to normal after animals were fasted, supporting the ability 
of leptin to affect change in the HPT (Legradi et al, 1997). ProTRH gene expression in 
the PVN is reduced during fasting and i.p. leptin has been shown to increase proTRH 
back to normal levels, showing that leptin can regulate expression of thyroid hormone 
mRNA. These data show that leptin can regulate thyroid hormones and the HPT axis and 
activate TRH-containing neurons in the PVN.  
 As mentioned above, leptin stimulates TRH release which acts through the HPT 
axis to result in the synthesis and release of T3 and T4, which have been shown to act in 
the hippocampus. T3 and T4 have been shown to decrease GABAergic currents in 
hippocampus cell cultures, thereby establishing another circuit that leptin could use to 
reduce inhibitory tone in the hippocampus to potentially pave the way for excitation and 
synaptic plasticity (Puia and Losi, 2011). To further establish the importance of thyroid 
hormones in the hippocampus, it has been shown in gestation day 6-old prenatal rats and 
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30 day-old postnatal rats that hypothyroidism can impair synaptic plasticity at area CA1 
of the hippocampus (Sui and Gilbert, 2003). The effect of neonatal hypothyroidism can 
extend to adulthood, as a study has found that LTP and synaptic transmission were 
impaired in adult rats (Gilbert and Paczkowski, 2003). This evidence of dysregulated 
thyroid hormones can show how leptin influence is important in LTP.  
 In addition to the ability of leptin to regulate the HPT axis through neurons in the 
PVN, it has also been shown that leptin can regulate oxytocin-containing neurons of the 
PVN. Levels of pSTAT3 were increased in oxytocin neurons, indicating that leptin had 
activated these neurons (Perello and Raingo, 2013). Leptin also regulates oxytocin 
mRNA expression in that fasted rats had significantly lower levels of oxytocin mRNA in 
the PVN compared to non-fasted controls. Interestingly, DIO rats showed activation of 
some of the oxytocin-containing neurons by i.c.v. leptin, as evidenced by pSTAT3 
(Perello and Raingo, 2013). This is an interesting result due to the decreased leptin 
signaling normally found in DIO animals and although not all of the oxytocin neurons by 
were activated by i.c.v. leptin, some were. This could mean that not all leptin signaling is 
inhibited in a leptin-resistant state, at least in some populations of the hypothalamus. 
(Perello and Raingo, 2015). 
 The ability of leptin to influence oxytocin release may be another indirect route 
that is used by leptin to facilitate synaptic plasticity in the hippocampus. Oxytocin 
receptors have been found on the hippocampus and animals given intranasal oxytocin 
performed better in the MWM (Lee et al, 2015). Neurogenesis has been shown to be 
affected by oxytocin, oxytocin was applied to a neural stem cell line and there was an 
increase in cell proliferation of progenitor cells (Musaelyan et al, 2011). These data show 
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that leptin can influence oxytocin neurons that can subsequently influence synaptic 
plasticity in the hippocampus, specifically enhancing learning and memory performance 
and stimulating neurogenesis in adults (Lee et al, 2015; Musaelyn et al, 2011).  
 Leptin receptors on TRH and oxytocin neurons show that leptin binding to its 
receptors in the PVN can regulate systems like the HPA and HPT and the release of many 
neurotransmitters which could in turn regulate synaptic plasticity in the hippocampus 
(Legradi et al, 1997; Perello and Raingo, 2013). Perhaps in addition to direct 
communication with the hippocampus using GABA and glutamate, leptin in the PVN 
also activates the release of other neurotransmitters that modulate synaptic plasticity. 
Additional hormones and systems that leptin can regulate in the PVN include 
corticotropin-releasing factor (CRF) and subsequent ACTH release from the pituitary, 
vasopressin, neurotensin and many others (Herman et al, 1989).  
 
4.6 LEPTIN RECEPTORS IN THE DORSOMEDIAL HYPOTHALAMUS 
 The dorsomedial nucleus of the hypothalamus (DMH), associated with food and 
water intake, has been shown to express leptin receptors (Bellinger and Bernardis, 2002; 
Schwartz et al, 1996; Elmquist et al, 1998). Immunohistochemistry and retrograde 
transport of cholera toxin b were used to determine which areas of the hypothalamus 
were excited by leptin administration, revealing double-labeling of Fos and the cholera 
toxin in the DMH (Elmquist et al, 1997). This indicates that leptin activated neurons in 
the DMH.  
 The neurotransmitter phenotype of DMH neurons is relatively unstudied, however 
a microarray study found that DMH neurons that contained NPY expressed glutamic acid 
 
79 
decarboxylase, suggesting that these neurons are GABAergic (Draper et al, 2010). 
Another study utilized transgenic mice to express GFP in choline acetyltransferase 
(ChAT) positive neurons, and found that cholinergic neurons are present in the DMH and 
are involved in energy homeostasis (Groessl et al, 2013). Additionally, tract tracing has 
revealed that the DMH projects to the PVN and releases both GABA and glutamate, 
additionally the DMH expresses both glutamate and GABA receptors (Myers et al, 2014; 
Silva et al, 2015; Boudaba et al, 1996; Ulrich-Lai et al, 2011). 
 The projections of the DMH were investigated using an adeno-associated virus 
that encoded GFP in combination with Cre recombinase so that only neurons in the DMH 
that also expressed leptin receptors would express Cre (Gautron et al, 2010). GFP 
expression was present in axonal projections of neurons with cell bodies in the DMH and 
the following brain regions contained terminals from the DMH: heavy projections to the 
arcuate, PVN, preoptic area, bed nucleus of the stria terminalis, supraoptic nucleus, 
lateral septum, parts of the thalamus, periacqueductal gray and precoeruleus areas. Less 
strong innervation was seen to the lateral hypothalamus, mammillary nuclei and dorsal 
raphe nucleus (Gautron et al, 2010).  
 The exact significance of these projections has yet to be determined, but it does 
establish several potential novel routes that leptin activates to have downstream effects in 
the hippocampus (Elmquist et al, 1997). The projections to the dorsal raphe nucleus and 
precoeruleus areas would add another layer of serotonergic and noradrenergic control, 
respectively, to the leptin receptors present in the raphe nucleus and locus coeruleus 
(Hay-Schmidt et al, 2001; Finn et al, 2000; Elmquist et al, 1998; Loughlin et al, 1986). 
The projections to the PVN and lateral hypothalamus may also add to the complexity of 
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leptin acting through various hypothalamic regions to control synaptic plasticity in the 
hippocampus (Gautron et al, 2010).  
 
4.7 LEPTIN RECEPTORS IN THE VENTROMEDIAL HYPOTHALAMUS 
 The ventromedial hypothalamic nucleus is involved in feeding and energy 
homeostasis, as lesions of this area result in obesity (Choi et al, 2013; Balagura 1970; 
Becker et al, 1974; Berthoud et al, 1979; King 2006). One study found a lack of obesity 
with lesioning of the VMH, however the findings of this study were unable to be 
replicated and have since been called into question (Gold et al, 1973). The VMH is also 
involved in fear responses, seen with an increase in Fos expression in the dorsomedial 
area of the VMH after mice were allowed to interact with a predator rat (Silva et al, 
2013). Interestingly, the same c-Fos activation was not seen during foot-shock (Silva et 
al, 2013). Because of this, the authors suggest a role for the VMH in social fear, which 
other studies support (Perez-Gomez et al, 2015). Thermoregulation, sexual activity and 
sympathetic control have also been found to involve the VMH, showing that the VMH 
plays a role in a variety of functions (Resch et al, 2011; Musatov et al, 2006). 
 The VMH releases glutamate, as seen by mRNA expression of VGLUT2, and 
projects to many regions, including the locus coeruleus, POMC neurons in the arcuate, 
and the hippocampus (Canteras et al, 1994; Ovesjo et al, 2001; Ziegler et al, 2002; Tong 
et al, 2007). The ventromedial nucleus projects directly to the entorhinal area of the 
hippocampus and it has been suggested that additional indirect routes to the hippocampus 
from the VMH nucleus are possible, mediated through the midline thalamic nuclei, 
amygdala, piriform area, endopiriform nucleus, and insula (Canteras et al, 1994). Other 
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regions that the VMH project to include the medial and lateral hypothalamus, bed nuclei 
of the stria terminalis and the periaqueductal gray (Canteras et al, 1994; Saper et al, 
1976). 
 Leptin plays a role in the VMH, specifically with glutamatergic steroidogenic 
factor-1 (SF1) -containing neurons and are involved in regulation of glucose levels 
(Dhillon et al, 2006; Tong et al, 2007; Vong et al, 2011). Electrophysiological whole-cell 
recordings revealed that leptin depolarizes and increases the frequency of action 
potentials in SF1 neurons (Dhillon et al, 2006). Other roles for SF1 neurons include body 
weight regulation, as evidenced by a mouse model lacking leptin receptors exclusively on 
SF1 neurons resulted in an increase in body weight as compared to controls (Dhillon et 
al, 2006). These data show that the lack of leptin binding disrupted the role of leptin to 
decrease feeding. Although no synaptic plasticity changes were measured, the 
connections of the glutamatergic VMH neurons to the hippocampus could also have been 
adversely affected by the knockout of leptin receptors. 
 In addition to leptin receptors on SF1 neurons, there are leptin receptors expressed 
widely in the VMH and these receptors are actively used, according to a study that looked 
at Fos expression and socs-3 mRNA (Bjorbaek et al, 1999; Elmquist et al, 1997). Leptin 
activates glutamatergic neurons in the VMH in addition to the glutamatergic SF1 
neuronal sub-population (Tong et al, 2007). These data are important in establishing a 
potential pathway starting in the VMH that leads to glutamate release in the hippocampus 
to stimulate NMDA-receptor mediated synaptic plasticity. In addition, the large number 
of brain regions that the VMH projects to could be a starting point for a network of 
excitatory influence on synaptic plasticity.  
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 These studies are significant in establishing an excitatory, glutamatergic indirect 
route that leptin can use to access the hippocampus. Leptin is excitatory on SF1 neurons 
in the VMH and other neurons in the VMH are glutamatergic as well, increasing the 
likelihood that leptin can result in glutamate release in the hippocampus to interact with 
NMDA and AMPA receptors. The implications of this excitatory input on synaptic 
plasticity in the hippocampus as a result of leptin binding in the VMH has not yet been 






Figure 4.1. Potential indirect pathways that leptin uses to influence synaptic plasticity in 
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CONCLUSIONS & FUTURE DIRECTIONS
Leptin has direct effects on synaptic plasticity in the hippocampus that clearly 
demonstrate the ability of leptin to enhance LTP, convert STP to LTP, traffic 
glutamatergic receptors to the membrane, increase calcium influx into the presynaptic 
neuron, increase dendritic spine density and increase cell proliferation (Oomura et al, 
2006; Wayner et al, 2004; Shanley et al, 2001; Garza et al, 2008; Dhar et al, 2014; 
O’Malley et al, 2007; Moult et al, 2010). In addition, leptin administration improves 
performance in several hippocampal-dependent learning and memory behavioral tests 
(Oomura et al, 2006; Rasi et al, 2006; Garza et al, 2008; Farr et al, 2006). The lack of 
leptin or impaired leptin signaling results in deficits in each of these measures of synaptic 
plasticity (Li et al, 2002; Dhar et al, 2014; Pinto et al, 2004; Ahima et al, 1999; Li et al, 
2002; Winocur et al, 2005; Grillo et al, 2011). Therefore, leptin has significant direct 
effects on synaptic plasticity, including learning and memory in the hippocampus.  
 Leptin is primarily peripherally synthesized, crosses the BBB and the long form 
of the leptin receptor mRNA and protein is expressed widely throughout the brain 
(Frederich et al, 1995; Banks et al, 1996; Hileman et al, 2002; Banks et al, 2006; 
Hakansson et al, 1998; Elmquist et al, 1998; Burguera et al, 2000; Huang et al, 1996; 
Hay-Schmidt et al, 2001; Ur et al, 2002; Figlewicz et al, 2003; Fulton et al, 2006; 
Leinninger et al, 2009; Hommel et al, 2006). Through several studies with 
immunocytochemistry to study the activation of these receptors by leptin with labeling 
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for pSTAT3, it has been confirmed that leptin utilizes these receptors and signals with 
them using the JAK/STAT signaling pathway, other studies have shown leptin receptors 
paired with the MAPK or PI3K pathways (Vong et al, 2011; Hommel et al, 2006; 
Leininger et al, 2009; Yadav et al, 2009; Perello and Raingo, 2013; Bates et al, 2003; 
Zhao et al, 2002b). Leptin binding to the ObRb has also been shown to alter membrane 
potential to either depolarize or hyperpolarize neurons (Cowley et al, 2001; van den Top 
et al, 2004; Guan et al, 2001; Powis et al, 1998; Dhillon et al, 2006; Goforth et al, 2014). 
Therefore, leptin acts in many regions of the brain and can result in excitation or 
inhibition of neurons.  
 The hypothalamus in particular has a high concentration of leptin receptor mRNA 
and a variety of effects as a result of leptin binding to its receptor (Elmquist et al, 1998; 
Cowley et al, 2001; van den Top et al, 2004; Goforth et al, 2014). The hypothalamus also 
projects widely, many nuclei sending reciprocal projections to each other as well as 
regions such as the hippocampus (Canteras et al, 1994; Cenquizca and Swanson, 2007; 
Herman et al, 1992; Morash et al, 1999; Ur et al, 2002; Tschop et al, 2000; Hsu et al, 
2015). It is proposed, then, that the hypothalamus acts as a central nexus that regulates 
many of the effects of leptin, be it food intake, energy expenditure or LTP in the 
hippocampus. The large number of regions that the VMH projects to in combination with 
its high level of glutamate release could be a jumping point to a broad network of a 
excitatory influence by leptin on synaptic plasticity (Canteras et al, 1994; Ovesjo et al, 
2001; Ziegler et al, 2002; Tong et al, 2007). Leptin activating or inhibiting neurons in the 
lateral hypothalamus that project to the amygdala, VTA, nucleus accumbens, locus 
coeruleus, raphe, and even other nuclei in the hypothalamus supports the idea of a 
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network that begins in the hypothalamus and projects widely, ultimately influencing 
synaptic plasticity through many circuits (Hahn and Swanson, 2015; Goto et al, 2005; 
Bjorklund and Dunnett, 2007a; Leshan et al, 2010; Lammel et al, 2008). The 
hypothalamus could be acting as a main point that not only diverges out to the rest of the 
brain but also a point that other areas converge to for synthesis of information. The 
hypothalamus could use multi-synaptic circuitry, by projecting to an area that 
subsequently projects to another to then finally to the hippocampus, creating a 
multiplying effect of the number of pathways that lead back to the hippocampus. The 
circuits proposed, with beginning points in the VTA, locus coeruleus, raphe nucleus, 
VMH, DMH, PVN and lateral hypothalamus provide strong evidence that leptin uses a 
combination of direct and indirect circuits for its effects.  
 It has been proposed that leptin activates or inhibits different circuits for the 
various effects of leptin on feeding, energy balance, reproduction, temperature regulation, 
and neuroendocrine control (Zhang et al, 1994; Flak and Myers, 2015). There are many 
brain regions involved in just control of feeding, including the arcuate, lateral 
hypothalamus, DMH, VMH, raphe nucleus, locus coeruleus and many others. Therefore, 
it is likely that leptin also utilizes its hypothalamic circuitry that projects to the 
hippocampus indirectly to enhance synaptic plasticity (Canteras et al, 1994; Gautron et al, 
2010).  
 The disperse nature throughout the brain of the feeding circuits alone lends credit 
to the idea that the regulation of synaptic plasticity is also disperse and that many 
interconnected brain regions are involved. For example, there are two groups of neurons 
in the arcuate nucleus that contain leptin receptors and are controlled by leptin in opposite 
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ways. The medial arcuate nucleus contains AgRP and neuropeptide Y (NPY) containing 
neurons while the lateral arcuate nucleus contains POMC neurons (Flak and Myers, 
2015). Leptin excites POMC neurons that release a-MSH, POMC, CART, GABA, 
acetylcholine while leptin inhibits medial arcuate nucleus AgRP neurons that can release 
AgRP, NPY and GABA (Bouret et al, 2004; Vong et al, 2011; Cowley et al, 2001; Kalra 
et al, 1999; Cone, 1999; Zigman and Elmquist, 2003). Both POMC and AgRP neurons 
project to three other food-related nuclei: PVN, DMH and lateral hypothalamus as well as 
many other brain regions (Bouret et al, 2004; Elias et al, 1999). This is only part of the 
circuitry involved in the regulation of feeding and demonstrates how far-reaching and 
complex the circuit can be. Synaptic plasticity circuits are likely just as complex and 
utilize several brain regions, neuron types and neurotransmitter systems. This idea is 
further supported by a study where deletion of STAT3 signaling in only the arcuate 
nucleus resulted in a small impact on body weight and feeding, illustrating how not just 
one region with leptin receptors signaling with the JAK/STAT pathway is responsible for 
body weight control (Gong et al, 2008; Buettner et al, 2006; Xu et al, 2007). This could 
apply to how leptin regulates several circuits and that the hippocampus is not the only 
brain region for leptin to act in to affect synaptic plasticity.  
 The nature of brain is such that different brain regions are interconnected and 
many of the regions that express leptin receptors project to the hippocampus (Hortnagl et 
al, 1991; Verney et al, 1985; Loughlin et al, 1986; Vertes et al, 1999; Azmitia and Segal, 
1978; Sawchenko et al, 1983; Willoughby and Blessing, 1987; Donovan and Tecott, 
2013; Petrov et al, 1992). Other studies have found both leptin mRNA or leptin receptors 
and Fos expression in other areas of the hypothalamus, including the VMH and PVN, 
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showing that leptin activates each of these areas (Elmquist et al, 1998; Schwartz et al, 
1996; Elmquist et al, 1997; Mercer et al, 1996). Determination of activation in the 
hypothalamus by leptin using a Fos and cholera toxin showed that leptin activated 
neurons in the DMH. However, the absence of Fos expression in other brain areas may 
indicate that leptin may have been inhibitory (Elmquist et al, 1997). Hyperpolarization in 
the hypothalamus after leptin application, seen with electrophysiology techniques, 
supports this hypothesis (Elmquist et al, 1997; Spanswick et al, 1997; Yamanaka et al, 
2003; Goforth et al, 2014). This shows that leptin both excites neurons and inhibits 
neurons even within just one brain area, the hypothalamus. Leptin exciting one area of 
the brain could cause downstream excitation in the hippocampus, enhancing synaptic 
plasticity indirectly. Conversely, leptin could inhibit an area of the brain, resulting in 
downstream lack of excitation in the hippocampus, either downregulating or reversing 
synaptic plasticity changes. This is an important function of leptin, the ability to both 
depolarize or hyperpolarize, depending on the location of the receptor in a brain region. 
This could allow for the balance of enhancements in learning and memory, a homeostatic 
type of regulation that is prevalent throughout the brain and body. In addition, the 
inhibitory effects of leptin allow for fine-tuning of excitation, to allow the execution of 
synaptic plasticity changes only when necessary or past a certain threshold. The manner 
in which leptin facilitates synaptic plasticity is in line with its characteristic of being 
neuromodulatory, not only directly altering synaptic plasticity but tweaking other areas 
for a combined effect.  
 Interestingly, several studies have reported that GABAergic neurotransmission is 
what predominately regulates feeding behaviors in the hypothalamus while also reporting 
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glutamatergic transmission that does not play much of a role except in preventing 
hypoglycemia (Vong et al, 2011; Tong et al, 2007). The effects of this glutamatergic 
transmission on synaptic plasticity in the hippocampus have not yet been studied, due to 
the nature of the studies focusing on feeding and energy expenditure. However, it 
certainly possible that the glutamate transmission in the hypothalamus influences the 
hippocampus. Some studies have even shown the relationship between the hippocampus 
and hypothalamus and how the hippocampus is involved with food-related memory and 
even regulation of the HPA axis by projections to the PVN (Bannerman et al, 2004; 
Kanoski et al, 2011, Herman et al, 1992; Myers et al, 2014; Herman et al, 1989). 
Glutamatergic transmission in the hypothalamus could be involved in the regulation of 
the HPA axis and food hippocampal-dependent learning and memory. This demonstrates 
the interconnected nature and complexity of the HPA axis and food intake regulation 
networks and how it is likely that hippocampal synaptic plasticity regulation is similarly 
complex and widespread. 
 Leptin has been shown to result in an inhibitory effect in some brain areas while 
having an excitatory effect in others, perhaps to balance its effects on feeding or synaptic 
plasticity so that neither is constantly being up- or down-regulated. Additionally, leptin 
could begin a network of excitatory pathways that begin in the hypothalamus, resulting in 
regions that were previously inhibited by leptin by direct action in these regions 
subsequently being depolarized through glutamatergic neurotransmission to induce 
synaptic plasticity in the hippocampus. To support this, other studies have suggested the 
idea that leptin acts through neural networks which contain leptin receptors (Fadel et al, 
2013; Leinninger and Myers, 2008; Myers et al, 2009; Scott et al, 2009). The distributed 
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model proposed by these studies for the feeding actions of leptin is applicable to the 
synaptic plasticity actions of leptin. The excitatory pathways beginning in the VMH, 
DMH, LH or PVN could be tempered by inhibition of excitatory neurotransmission 
coming from the locus coeruleus, raphe or VTA. These networks would work in harmony 
and be controlled by leptin.  
 Future studies should take measures of hippocampal synaptic plasticity, for 
example using electrophysiology to measure LTP or conduct hippocampal learning and 
memory-dependent behavioral studies after directly injecting leptin into one of the 
potential areas that would begin a circuit. Confirmation of circuits could provide the 
knowledge of how normal physiology works to allow for greater understanding of 
pathology and the development of better treatment of diseases where leptin is 
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